© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
[2026] NSWSC 579
Supreme Court of NSW
2026-05-28
Rees J
Original judgment source is linked above.
Source: NSW Caselaw (www.caselaw.nsw.gov.au). Converted to plain text by ZoeLaw. Not the official version.
Medium Neutral Citation: Sphere Healthcare Pty Ltd v Allianz Australia Insurance Ltd [2026] NSWSC 579
Hearing dates: 8 – 9 September 2025, 15 – 18 December 2025
Date of orders: 28 May 2026
Decision date: 28 May 2026
Jurisdiction: Equity - Commercial List
Before: Rees J
Decision: Summons dismissed.
Catchwords: INSURANCE — insured manufactures health care products and infant formula — COVID-19 pandemic — insured decides to make hand sanitiser — insured also seeks industrial special risks (ISR) policy with $26.8 million limit of indemnity — insured imports bulk ethanol, exceeding capacity of dangerous good area — ethanol placed next to factory — fire — total loss — whether insured entitled to indemnity.
BROKERS — broker arranges ISR policy — insured changes broker — former broker cancels policy — whether authority to cancel policy — principles at [202]-[205] — policy remained on foot.
DUTY OF DISCLOSURE — agreement to vary the contract — s 11(9), Insurance Contracts Act 1984 (Cth) — policy schedule and wording completely replaced — scope of duty of disclosure — principles at [214]-[221] — duty applied to matters material to whole contract — whether duty of disclosure complied with — s 21(1)(b), Insurance Contracts Act — principles at [301]-[305] — duty not complied with.
WAIVER — s 21(2)(d), Insurance Contracts Act — principles at [277]-[283] — no fair presentation of the risk — insurer not put on enquiry.
ENDORSEMENT — unintended or inadvertent non-disclosure — proper construction at [236]-[239].
ENDORSEMENT — alteration in risk — whether alteration “neither known to nor made by an officer of the Insured who is responsible for Insurance” — proper construction at [249]-[257].
INSURANCE — remedies — whether insurer entitled to reduce liability to nil under s 28(3), Insurance Contracts Act — whether insurer entitled to refuse to pay insured’s claim under s 54(2), Insurance Contracts Act — principles at [326]-[328] —insurer entitled to relief sought.
ADMISSIONS — ss 81, 87, Evidence Act 1995 (NSW) — principles at [25]-[32] — deponent not a party to proceedings nor employee of a party — plaintiffs part of corporate group which employed deponent — deponent did not thrust himself on the court to give evidence in the plaintiffs’ case but was chosen by them — “reasonably open to find” that he had authority to make admissions.
JONES v DUNKEL — inference where onus of proof is not on you — principles at [14]-[18] — inference may still be drawn.
Sphere Healthcare Pty Ltd
Allianz Australia Insurance Ltd
Legislation Cited: Biosecurity Act 2015 (Cth), ss 42, 475
Biosecurity (Human Biosecurity Emergency) (Human Coronavirus with Pandemic Potential) Declaration 2020
Biosecurity (Listed Human Diseases) Amendment Determination 2020
Evidence Act 1995 (NSW), ss 59, 81, 87
Insurance Contracts Act 1984 (Cth), ss 11, 21, 28, 54
Public Health Act 2010 (NSW)
Cases Cited: ABN AMRO Bank NV v Bathurst Regional Council (2014) 224 FCR 1; [2014] FCAFC 65
Advance (NSW) Insurance Agencies Pty Ltd v Matthews (1989) 166 CLR 606; [1989] HCA 22
Allianz Australia Insurance Ltd v Haddad [2015] NSWCA 186
Arterial Caravans Ltd v Yorkshire insurance Co Ltd [1973] 1 Lloyd’s Rep 169
Asfar & Co v Blundell [1896] 1 QB 123
Australian Competition and Consumer Commission v BlueScope Steel Ltd (No 3) [2021] FCA 1147
Australian Competition and Consumer Commission v World Netsafe Pty Ltd (No 2) (2002) 119 FCR 307; [2002] FCA 517
Booth v Bosworth (2001) 114 FCR 39; [2001] FCA 1453
Carter v Boehm (1766) 3 Burr 1905
CGU Insurance Ltd v Porthouse (2008) 235 CLR 103; [2008] HCA 30
Codelfa Construction Pty Ltd v State Rail Authority (NSW) (1982) 149 CLR 337; [1982] HCA 24
Commercial Union Assurance Co of Australia Ltd v Beard (1999) 47 NSWLR 735; [1999] NSWCA 422
Commonwealth v Helicopter Resources Pty Ltd (2020) 270 CLR 523; [2020] HCA 16
Cook’s Construction Pty Ltd v Brown [2004] NSWCA 105
Cory v Patton (1872) LR 7 QB 304
Council of the City of Wollongong v Vero Insurance Limited [2009] NSWSC 475
Deaves v CML Fire & General Insurance Co Ltd (1979) 143 CLR 24; [1979] HCA 12
Doppstadt Australia Pty Ltd v Lovick & Son Developments Pty Ltd [2014] NSWCA 158
Esined No.9 v Moyland Retirement Solutions (No 2) [2020] NSWSC 359
Federation Insurance Ltd v Wasson (1987) 163 CLR 303; [1987] HCA 34
Ferrcom Pty Ltd v Commercial Union Assurance Co of Australia Ltd (1993) 176 CLR 332; [1993] HCA 5
GIO General Ltd v Wallace [2001] NSWCA 299
GLJ v Trustees of Roman Catholic Church for Diocese of Lismore (2023) 280 CLR 442; [2023] HCA 32
Hayes v 5G Developments Pty Ltd [2019] FCA 1541
Hitchens v Zurich Australia Ltd [2015] NSWSC 825
Ho v Powell (2001) 51 NSWLR 572; [2001] NSWCA 168
Ingot Capital Investments Pty Ltd v Macquarie Equity Capital Markets Ltd (No 4) [2006] NSWSC 90
J&J Richards Super Pty Ltd v Nielsen [2024] FCA 1472
Jones v Dunkel (1959) 101 CLR 298; [1959] HCA 8
Kausar v Eagle Star Insurance Co Ltd [2000] Lloyd’s Rep IR 154
Kodak (Australasia) Pty Ltd v Retail Traders Mutual Indemnity Insurance Association (1942) 42 SR (NSW) 231
Lishman v Northern Maritime Insurance Co (1875) LR 10 CP 179
Lindsay v CIC Insurance Ltd (1989) 16 NSWLR 673
Manifest Shipping Co Ltd v Uni-Polaris Shipping Co Ltd [2001] UKHL 1
McCann v Switzerland Insurance Australia Ltd (2000) 203 CLR 589; [2000] HCA 65
Moltoni Corporation Pty Ltd v QBE Insurance Ltd (2001) 205 CLR 149; [2001] HCA 73
Onley v Catlin Syndicate Ltd [2018] FCAFC 119
Pacific & General Insurance Co Ltd v Hazell [1997] LRLR 65
Permanent Trustee Australia Ltd v FAI General Insurance Company Ltd (in liq) (2003) 213 CLR 514; [2003] HCA 25
Prepaid Services Pty Ltd v Atradius Credit Insurance NV [2014] NSWCA 440
Prime Forme Cutting Pty Ltd v Baltica General Insurance Company Ltd (1991) 6 ANZ Insurance Cases 61-028
Qantas Airways Ltd v Transport Workers’ Union of Australia [2011] FCA 470
QBE Insurance (International) Ltd v Jaggar [2007] 2 NZLR 336
QBE Underwriting Ltd as managing agent for Lloyds Syndicate 386 v Southern Colliery Maintenance Pty Ltd (2018) 97 NSWLR 459; [2018] NSWCA 55
Re Palmdale Insurance Ltd (in liq) [1982] VR 921
Refina Pty Ltd v Binnie [2009] NSWSC 311
Ronchi v Portland Smelter Services Ltd [2005] VSCA 83
Roumeli Food Stores (NSW) Pty Ltd v The New India Assurance Co Ltd [1972] 1 NSWLR 227
Seven Cable Television Pty Ltd v Telstra Corporation Ltd [2000] FCA 350
Stealth Enterprises Pty Ltd t/as The Gentleman’s Club v Calliden Insurance Ltd [2017] NSWCA 71
Tim Barr Pty Ltd v Narui Gold Coast Pty Ltd [2008] NSWSC 1247
Wallaby Grip Ltd v QBE Insurance (Australia) Ltd (2010) 240 CLR 444; [2010] HCA 9
Waverley Council v Tovir Investments Pty Ltd (No 2) [2013] NSWLEC 21
WISE Underwriting Agency Ltd v Grupo Nacional Provincial SA [2004] EWCA Civ 962
Wright v Optus Administration (No 5) [2013] NSWSC 1717
Xenos v Wickham (1867) LR 2 HL 296
XL Insurance Co SE v BNY Trust Company of Australia Ltd [2019] NSWCA 215
Zurich Australian Insurance Ltd v Cimic Group Ltd (2024) 115 NSWLR 297; [2024] NSWCA 229
Zurich Australian Insurance Ltd v Metals and Minerals Insurance Pte Ltd (2009) 240 CLR 391; [2009] HCA 50
Texts Cited: AS/NZS 1905.1:1997 Components for the Protection of Fire-resistant Walls, Part 1: Fire-resistant Doorsets
Australian and New Zealand Standard Industrial Classification 1993
Australian Standard 1940:2017 The Storage and Handling of Flammable and Combustible Liquids
D Kelly & M Ball, Principles of Insurance Law (2024, LexisNexis, looseleaf)
JW Carter, Contract Law in Australia (8th ed, 2023, J W Carter Publishing)
NC Seddon and RA Bigwood, Cheshire & Fifoot Law of Contract (11th Australian ed, 2017, LexisNexis Butterworths)
P Mann, Mann’s Annotated Insurance Contracts Act (9th ed, 2024, Lawbook Co)
WIB Enright, RM Merkin and F Hawke, Sutton on Insurance Law in Australia, (5th ed, 2025, Lawbook Co)
Category: Principal judgment
Parties: Sphere Healthcare Pty Ltd (First Plaintiff)
Yes Family Pty Ltd (Second Plaintiff)
Allianz Australia Insurance Ltd (Defendant)
Representation: Counsel:
MA Jones SC / E Steer (Plaintiffs)
D Lloyd SC / C O’Neill (Defendant)
Solicitors:
Herbert Smith Freehills Kramer (Plaintiffs)
Carter Newell Lawyers (Defendant)
File Number(s): 2022/269876
JUDGMENT
Onus and inferences
Admissions
Storing ethanol
Earlier policies
Change of management
Hand sanitiser
Requesting a quote from Allianz
Progressing hand sanitiser project
Changing brokers
New policy wording
Subsequent events
The fire
Was the contract of insurance cancelled?
Consideration
What about the new wording?
Consideration
Exception: inadvertent non-disclosure
Was the duty of disclosure waived under s 21(2)(d)?
Consideration
Was any duty of disclosure complied with?
Consideration
Exception: alteration in risk
The counter factual
The task
The evidence
Consideration
Orders
HER HONOUR: Hand sanitiser was highly prized in the early days of the COVID-19 pandemic. The Aunew group of companies wanted to start making it. The group had recently acquired the first plaintiff, Sphere Healthcare Pty Ltd, under a deed of company arrangement (DOCA). Sphere had been manufacturing therapeutic goods for years at a factory in Moorebank. Sphere leased the premises from the second plaintiff, Yes Family Pty Ltd, which, as it happened, was part of the Aunew group too.
An Aunew company, GMP Pharmaceuticals Pty Ltd, was now running Sphere’s business and was keen to start manufacturing hand sanitiser at Moorebank. A customer had placed an order. The problem was sourcing enough ethanol. Local suppliers were “on allocation” and were unable to supply large quantities. GMP and Sphere’s procurement officers worked hard – with some success – to source the ingredient. But GMP decided to import a large quantity of ethanol from China.
In parallel, Aunew Group Holdings Pty Ltd (Aunew) was working with three insurance brokers to source insurance for the Aunew group. For several years, Sphere had been insured by the defendant, Allianz Australia Insurance Ltd, under an Industrial Special Risks (ISR) policy. But the policy was cancelled when Sphere was in administration. Aunew’s broker, Ansin Insurance Brokers Pty Ltd (the WA broker), approached Allianz for cover once more. On 20 March 2020, Allianz’s WA branch bound cover on an ISR policy for Sphere, having been assured by the WA broker that there was “no change in business activity” even though Sphere was now being operated by GMP / Aunew.
But Aunew changed brokers to Australasia Insurance Brokers Pty Ltd (the NSW broker). Aunew wanted to keep the ISR policy which the WA broker had arranged. The NSW broker asked Allianz to transfer the ISR policy, while the WA broker asked Allianz to cancel it. After some confusion caused by the fact that the NSW broker’s letter of appointment was back-dated, Allianz’s NSW branch issued a new policy schedule and wording but for the same premium. The limit of indemnity was $26.8 million. Sphere and its landlord, Yes Family, were the insureds.
Within days, Sphere ordered 60,000 L of ethanol from Shanghai. When delivered, the 304 drums of ethanol were not stored in Sphere’s dangerous goods storage area but double-stacked in an “old dispatch area” adjacent to the Moorebank factory, along with pallets of cardboard. On 9 July 2020, a fire started near the cardboard. The nearby drums of ethanol limited the fire brigade’s ability to douse that fire. Instead, the fire brigade turned their hoses “onto exploding ethanol drums to attempt to slow a running ethanol fire in the drains”. Attempts to cut off the fire heading towards the factory proved unsuccessful and the building was lost.
After the fire, Allianz learned that Sphere had been manufacturing hand sanitiser and poorly storing large quantities of ethanol on site. The insurer refused to pay the claim. The insureds now seek a declaration that they are entitled to indemnity. The issues are:
(a) When was the contract of insurance formed, specifically, was the cover bound on 20 March 2020 cancelled by the WA broker and, if not, what is the effect of the later policy schedule and wording? (b) Did the insurer waive any requirement for Sphere to comply with its duty of disclosure, either under Condition 1 of the policy (in respect of “unintended and/or inadvertent” non-disclosure) or s 21(2)(d) of the Insurance Contracts Act 1984 (Cth)? (c) If not, did Sphere comply with the duty of disclosure, either on 20 March 2020 or any subsequent date that the policy was varied or a new contract of insurance formed? (d) Was the alteration in risk brought about by bulk ethanol on site and the production of hand sanitiser “neither known to nor made by an officer of the Insured who is responsible for Insurance”, such that the insurer remains liable for loss caused by the alteration in risk after inception of the policy under Condition 2? (e) Is the insurer’s liability reduced to nil, either under ss 28 or 54 of the Insurance Contracts Act?
Issues such as these are often efficiently resolved by reference to contemporaneous documents. There were two problems here. First, the contemporaneous documents are not easy to follow, given different timestamps on multiple copies of emails passing between Perth, Melbourne, Sydney and Auckland. I have endeavoured to set out events in strict chronological sequence, where it matters.
Second, emails are sometimes incomplete or missing attachments. Of concern, there appear to be gaps in documentation at critical moments. Specifically, on 23 March 2020, when GMP canvassed the possibility of importing ethanol from China, there are no documents evidencing the negotiation with the Chinese supplier referred to in the only contemporaneous email: see [133]. More significantly, there are no documents from 23 March 2020 until a purchase order was placed with the Chinese supplier on 3 April 2020: see [179]. Events over that period may be critical to determining the issues in this case.
As to the underwriting of the policy, the insurer called a risk consultant in the Allianz Risk Consultants Australia (ARCA) Team, Constantine Iordanou, underwriter Dirk Keuneman, senior underwriters Ubaldine (Dina) Lobo and Clinton Pan and the general manager of Allianz Tailored Solutions (ATS), Michael Pocknee. As to the fire event, the insurer called forensic fire examiner Nikola Sutarov and Sphere’s warehouse team leader, Jose Urbina. The insurer also relied on the expert evidence of forensic scientist James Munday. All but Mr Munday were cross-examined. No issues of credit arose.
The insureds called no witnesses. This brings me to the first controversy.
Three witnesses closely involved with relevant events were going to give evidence for the insureds but did not. Gang (Gerry) Yin and Liangyu (Sam) Zeng dealt with insurance matters for the Aunew group. On the operational side, the insureds had planned to call Zhen (Vincent) Cai.
The insurer submitted that the Court should infer that Mr Cai’s evidence would not have assisted Sphere’s case on the issue of actual knowledge of the decision to make hand sanitiser. GMP’s Group Deputy General Manager, Lakvinder (Lucky) Singh was also “front and centre” and there was no explanation for why he was not called. Further, to the extent that the insureds sought to rely on Condition 1, which depended on proving that any error, omission or misdescription of the risk was “unintended and/or inadvertent”, the insureds chose not to call the officer responsible for insurance, being Mr Zeng. Inferences could more confidently be drawn in the insurer’s favour in these circumstances: Doppstadt Australia Pty Ltd v Lovic**k & Son Developments Pty Ltd [2014] NSWCA 158 at [14] (Emmett JA), [81] (Gleeson JA, Ward P agreeing).
The insureds submitted that the onus of proof was on the insurer to establish its defences: Wallaby Grip Ltd v QBE Insurance *(*Australia) Ltd (2010) 240 CLR 444; [2010] HCA 9 at 459. The insureds bore no onus and their election not to call witnesses was said to be no more than a reflection of the insurer's pleaded case and the evidence led in support of that case.
I accept that it was not necessary for the insureds to call Mr Zeng in respect of particular parts of the case, where the insurer had pleaded a contention and the insureds had admitted that contention. But beyond this, the fact that the onus of proof is on the insurer is not a complete answer. Jones v Dunkel (1959) 101 CLR 298; [1959] HCA 8 was itself a case where an adverse inference was drawn against a party who did not bear the onus of proof. As Hodgson JA (Beazley JA and Davies AJA agreeing) explained in Ho v Powell (2001) 51 NSWLR 572; [2001] NSWCA 168 at [16]:
“The case of Jones v Dunkel … itself related to a situation where there was evidence supporting an inference against a party, and that party did not give or call evidence, which that party was plainly in a position to have given or called, in order to explain or contradict the material presented. In my opinion, a similar principle applies where a person bearing the onus of proof does not give or call evidence which that person is plainly in a position to give or call …”
“…If the person that the court is considering is a person who does not bear the onus of proof and that person fails to call a witness, the inference may be drawn that the witness is not likely to assist the person’s case. That is Jones v Dunkel itself.”
“I conclude that the appropriate approach for me to adopt in this case having regard to the failure of the respondents to give evidence is as follows:
(a) as the burden of proof with respect to each of the facts in issue between the parties lies on the applicant, the applicant must establish evidence of each of the facts in issue notwithstanding that some relevant and important evidence is peculiarly within the knowledge of the respondents;
(b) the failure of the respondents to give evidence does not of itself amount to proof of any fact in issue;
(c) however, provided that there is before the Court evidence tending to establish each of the facts in issue (albeit that it may be "meagre in the extreme" - see Jones v Dunkel per Kitto J at 305), in assessing the probability of the existence of a fact in issue (ie in weighing the evidence on that issue) use may be made of the failure of the respondents to give evidence apparently in their possession relevant to that fact in issue. That is, it is open to the Court to draw the inference that the evidence which the respondents could have given to the Court would not have been favourable to their case and thus more confidently to draw inferences available to be drawn from the evidence that is before the Court.”
An example in the insurance context is Prepaid Services Pty Ltd v Atradius Credit Insurance NV [2014] NSWCA 440. The insurer declined indemnity on the basis of non-disclosure. While the insurer bore the onus of proving that it would not have issued the policy if the non-disclosure had not occurred, the insured “had an evidentiary burden of establishing that it would have provided information” to the insurer if asked, and the content of that information: at [52] (Macfarlan JA, Meagher JA and Sackville AJA agreeing). Otherwise, the insured “ran the risk that if it did not lead evidence of matters that it would have put before [the insurer] to attempt to persuade it to issue the policy … the court might accept [the insurer’s] evidence and conclude that [its] defence succeeded”: at [56].
Further, as the insurer submitted, the onus of proof to establish that the insured falls within the exception to an exclusion rests on the insured: WIB Enright, RM Merkin and F Hawke, Sutton on Insurance Law in Australia (5th ed, 2025, Lawbook Co) at [9.230], see also XL Insurance Co SE v BNY Trust Company of Australia Ltd [2019] NSWCA 215 at [65] (Gleeson JA, Bell P and Emmett AJA agreeing).
The insurer submitted that the Court should draw a more benign inference than that the evidence of these witnesses would not have assisted the insureds’ case. Rather, the Court should not draw inferences in the insureds’ favour. As Hodgson JA explained in Cook’s Construction v Brown at [42]:
“…where a party has to prove something and prima facie has available evidence that would directly deal with the question, a court will be very hesitant in drawing an inference in that party’s favour from indirect and second-hand evidence, when the party doesn’t call the direct evidence that prima facie it could have called, at least unless some explanation is given, or the circumstances themselves provide an explanation...”
This brings me to an evidentiary issue that was reserved for this judgment. When the insureds did not call Mr Cai, the insurer tendered portions of Mr Cai’s three affidavits. The insureds objected on the basis that Mr Cai’s affidavits did not contain “admissions made with authority” within the meaning of s 87 of the Evidence Act 1995 (NSW).
The insureds submitted that Mr Cai was not a party. He was not an employee of the parties either, but employed by GMP. GMP was not a party either, nor was Sphere a subsidiary of that company. The fact that the companies were “friends” did not give rise to authority to make admissions. At the time Mr Cai made the affidavits, he was not authorised “in any sensible way” to make admissions on behalf of the insureds.
Mr Cai’s affidavits are “evidence of a previous representation” and inadmissible as hearsay: s 59, Evidence Act. But the hearsay rule does not apply to evidence of an admission: s 81(1), Evidence Act*.* The Dictionary to the Evidence Act defines “admission” as follows:
admission means a previous representation that is—
(a) made by a person who is or becomes a party to a proceeding, and
(b) adverse to the person’s interest in the outcome of the proceeding.
Admissions made with authority
(1) For the purpose of determining whether a previous representation made by a person is also taken to be an admission by a party, the court is to admit the representation if it is reasonably open to find that—
(a) when the representation was made, the person had authority to make statements on behalf of the party in relation to the matter with respect to which the representation was made, or
(b) when the representation was made, the person was an employee of the party, or had authority otherwise to act for the party, and the representation related to a matter within the scope of the person’s employment or authority, or
…
(2) For the purposes of this section, the hearsay rule does not apply to a previous representation made by a person that tends to prove—
(a) that the person had authority to make statements on behalf of another person in relation to a matter, or
(b) that the person was an employee of another person or had authority otherwise to act for another person, or
(c) the scope of the person’s employment or authority.
Consistently with s 87(2), the whole of Mr Cai’s first affidavit was tendered on the voir dire. Four points bear noting in respect of the admissibility of an admission under ss 81 and 87 of the Evidence Act.
First, admitting an admission does not require a concluded finding on the person’s authority: Ingot Capital Investments Pty Ltd v Macquarie Equity Capital Markets Ltd *(*No 4) [2006] NSWSC 90 at [11] (McDougall J). As Barrett J put it in Tim Barr Pty Ltd v Narui Gold Coast Pty Ltd [2008] NSWSC 1247 at [11]:
“… the words "it is reasonably open to find" in s 87(1.) … make it clear that the court does not have to make a finding as to the relevant matter. The court merely has to see that there is a reasonable basis upon which the finding might ultimately be made. The thing to be determined on the balance of probabilities is the existence of the reasonable basis, not the existence of the ultimate conclusion as to authority, scope of employment or furtherance of a common purpose…”
But nor should one simply rely on the person’s assertion that they had authority to make the admission: Australian Competition and Consumer Commission v World Netsafe Pty Ltd *(*No 2) (2002) 119 FCR 307; [2002] FCA 517 at [15] (Spender J).
Second, s 87 focuses on the time when the admission is made and the authority of the person to make the admission at that time: Ingot at [10]-[11]; Hayes v 5G Developments Pty Ltd [2019] FCA 1541 at [35] (Stewart J); Australian Competition and Consumer Commission v BlueScope Steel Ltd *(*No 3) [2021] FCA 1147 at [15] (O’Bryan J).
Third, s 87 provides “two pathways to admissibility… One pathway relates to the question of authority, as that question might be understood … in the law of agency; the second pathway relates to the scope of a person’s employment”: Wright v Optus Administration *(*No 5) [2013] NSWSC 1717 at [13] (Campbell J). His Honour considered the second pathway to be “much broader”, such that “[o]nce one is satisfied that the person making the representation is an employee of the party then the second aspect is only that the representation related to a matter within the scope of the person's employment. It is not necessary to prove that the employee had actual or ostensible authority to make representations on behalf of the party”: at [18].
The broad scope of the second pathway is referrable to the legislative history of the provision, as explained in Commonwealth v Helicopter Resources Pty Ltd (2020) 270 CLR 523; [2020] HCA 16 at [18] (Kiefel CJ, Bell, Gageler, Keane, Nettle and Gordon JJ):
“Section 87(1)(b) of the Evidence Act departs from the common law primarily by extending the range of employees and agents whose representations may be treated as admissions against their employers or principals: from those having authority to make representations on the latter's behalf to those not so authorised but whose representations relate to a matter within the scope of their employment or authority…. Hence, as the Australian Law Reform Commission explained in the recommendation that spawned s 87(1)(b), the change which it effected was to improve the fairness of the adversary process:
‘The primary argument for permitting an ‘admission’ by a third party to be proved against a party is based on the adversary nature of the trial system. It is fair to allow a party to be held responsible for an assertion made by a third party if that third party is an agent of the party acting under his authority. Thus, an admission made by a managing director should be admissible against the company, even if arguably unreliable, because he either had actual authority to make the admission or was put in a position where a reasonable observer would assume he had such authority. … [I]t would seem that the best approach is to impose a requirement of authority to speak or a requirement that the statement relate to an area of personal responsibility.’” (Footnotes omitted.) (Emphasis added.)
But even the first pathway is not narrow. As McDougall J observed in Ingot, “the legislation is looking at the general authority of the person whose previous representation is sought to be tendered to make statements of the kind embodied in the particular representation, and not at the authority to make the particular representation …”: at [20].
To illustrate both pathways, and while most of the case law concerns employees, s 87 was applied to admissions made by a union delegate in Qantas Airways Ltd v Transport Workers’ Union of Australia [2011] FCA 470 at [34] (Moore J) and to admissions by an independent contractor in Refina Pty Ltd v Binnie [2009] NSWSC 311 at [6] (Brereton J, as his Honour then was). In Waverley Council v Tovir Investments Pty Ltd (No 2) [2013] NSWLEC 21, promotional material on two websites was admitted under s 87, where a Council was prosecuting property owners for using their properties for backpacker accommodation in Bondi. Biscoe J found that the websites were associated with the owners, and the websites promoted the properties with the owners’ permission or acquiescence: at [29].
Turning to the case at hand, my focus is on Mr Cai’s authority to make admissions at the time of his affidavits, being 3 March 2023, 9 June 2023 and 12 April 2024. I am not concerned with Mr Cai’s authority when insurance was placed, or the decision was made to manufacture hand sanitiser, or the decision was made to order ethanol from China. Two things are relevant here: Mr Cai’s employment within the Aunew group, and how the insureds fit within that group.
As to the first matter, Mr Cai was employed by GMP in 2017 before being employed by Aunew as Group Planning Resources Manager in 2019. After Sphere was acquired by the Aunew group, Mr Cai relocated to Moorebank to manage production processes. In June 2020, shortly before the fire, Mr Cai was promoted to Deputy General Manager with Aunew and took on more of a leadership position in the business. Since August 2020, Mr Cai has held his current role as Deputy Site Manager with GMP, focussing on production planning and warehousing. He has continued to be involved with the insurance claim the subject of these proceedings.
Turning to the second matter, company searches and communications between Aunew and its brokers indicate that Sphere, Yes Family, GMP and Aunew are related companies owned by Qing (Karl) Ye and his family. Mr Cai said there were synergies between the businesses and operations of Sphere and GMP, given the similarities in their product offering and customer base. GMP had sites near Moorebank. There was often business collaboration between these entities. That is, although the insureds, GMP and Aunew are distinct corporate entities, they worked together and for the benefit of the common owners, being Mr Ye and his family.
It is true that Mr Cai was not an employee of Sphere or Yes Family at the time that he made his three affidavits. He was employed by Aunew but worked for GMP. But the very fact that he was chosen by Sphere and Yes Family to make affidavits in support of their case indicates that they conferred authority on Mr Cai to make the statements in his affidavits on their behalf when the affidavits were made: s 87(1)(a), Evidence Act. Mr Cai has not thrust himself upon the Court. He was selected by the insureds to give evidence in their case.
Further, Mr Cai has been involved with the insurance claim the subject of these proceedings since the fire. This suggests that making affidavits in support of the insureds’ claim is within the scope of his employment or authority, whether his employer is Aunew or GMP: s 87(1)(b), Evidence Act. I admit the portions of Mr Cai’s affidavits tendered by the insureds, as I consider that it is “reasonably open to find” that he had authority to make the admissions.
To assist in what follows, Sphere’s manufacturing facility in Moorebank covered some 15,000 m2 of building space and 31,000 m2 of land. Up to 250 employees worked there.
Sphere used ethanol in its manufacturing facility. Ethanol is a flammable liquid for the purposes of Australian Standard 1940:2017 The Storage and Handling of Flammable and Combustible Liquids (AS 1940:2017). Sphere had a permit from the Australia Taxation Office to receive concessional spirits, including 260,000 L of alcohol per year for manufacture of pharmaceuticals. Sphere had a designated external bunded storage area which was used for the storage of dangerous goods, including alcohol. Mr Sutarov explained that a bunded area has a barrier around the perimeter, which prevents liquid escaping.
Sphere ordered its ethanol from Wilmar BioEthanol (Australia) Pty Ltd. Ethanol was delivered in intermediate bulk containers (IBCs), which are big stainless steel tanks that contain 808 kg (or 1,000 L) of ethanol. Mr Urbina said the IBCs were placed in cages in the dangerous goods area and empty IBCs were removed from the cages. That is, ethanol was pumped directly from the IBCs into the factory rather than moving the IBCs.
Mr Urbina said that ethanol was ordered when required for production rather than, say, a scheduled delivery. He said, “they probably won’t order it up until it was necessary”, and “… sometimes we received two IBCs, sometimes we received three, and they pick up the [IBCs] that was empty.” In evidence is a bundle of invoices from Wilmar BioEthanol from 2016 on. A review of these invoices to the end of 2019 (when Sphere was acquired by the Aunew group) indicates that Sphere took delivery of ethanol, on average, every 11.65 days and the deliveries were, on average, 1,170.53 kg (or 1,449 L). Put another way, on average, Sphere used one IBC of ethanol a week. These deliveries continued in 2020, in addition to the bulk deliveries which are the subject of this judgment.
Alongside the bunded area and adjacent to the factory was an old dispatch area, which was used for overflow storage. This area was covered by a canopy. Access from the old dispatch area to the factory was via a roller door. According to expert forensic scientist, Mr Munday, the old dispatch area was not a compliant structure in which to store flammable liquids. Nor did the old dispatch area comply with AS 1940:2017 in respect of the containment of leaks and spills; there was no bund and there was unrestricted drainage to the stormwater drain alongside the driveway. Further, AS 1940:2017 required any opening between the storage area and the factory to have a sliding or outward opening automatic-closing fire door which complied with AS/NZS 1905.1:1997 Components for the Protection of Fire-resistant Walls, Part 1: Fire-resistant Doorsets and fitted with a thermal release device. There was no such door here. Mr Munday concluded that the old dispatch area did not conform with the requirements of AS 1940:2017 as a flammable liquid package store. The insureds did not suggest otherwise.
Given the way that the insureds put their case on waiver of the requirement to comply with the duty of disclosure, it is necessary to start with the first policy written by Allianz for Sphere. Tracking through this history is assisted by the fact that underwriting documents at Allianz were saved on a “Teamworks” file. Emails, documents, messages and underwriting notes were saved on Teamworks as the risk was assessed. Documents from earlier policy periods were available to anyone with Teamworks access.
In 2008, Sphere’s then broker, Gallagher Broking Services Pty Ltd, commissioned risk consultant Vero to inspect the Moorebank premises, presumably to assist in obtaining insurance. Vero’s report was generally positive, making a series of recommendations the implementation of which was considered sufficient to improve the insured’s rating from “Gold” to “Platinum”. Sphere’s business was described as follows:
“This business is a licensed Therapeutic Goods Administration (TGA) large-scale pharmaceutical contract manufacturer catering to a global market. It produces on behalf of numerous clients a wide range of market ready vitamin, mineral, other nutraceutical ingredients and herbal formulations. … The extensive manufacturing range available is:
Vitamin and mineral supplements
Herbal formulations
Health and beauty products
Creams, ointments and gels
Sports foods
Veterinary products (no steroids)”
“1.4 Management of Risks
Highly flammable bulk liquids are warehoused externally in a purpose built well ventilated enclosure having adequate bunding to capture any liquid leakages from 1000L IBC (intermediate [bulk] containers). Pipe pumped, liquid is flow control/monitored to small dispensing containers inside the building. …”
“In addition bulk packaged (IBC) of a class 3 flammable (ethanol) are received and held on site with this product used in the tablet manufacturing process.
… The mixture of diversified raw materials and packaging is deemed overall to represent a moderate to high fire load.”
“Hazardous Storage & Processes
4x1000l capacity IBCs hold ethanol with an approved/floor bunded enclosure. On a needs basis, ethanol is pipe pumped from these IBCs to an intermediate tank(s) of approximately 80l in the soft gel capsule manufacturing area. The amount of liquid pumped and dispensed is strictly controlled via solenoid valves. …
Dangerous Goods
In the case of Class 3 (flammables), these are held external to the building in 1000l capacity IBCs in an approved well ventilated and adequately floor bunded freestanding enclosure.”
In May 2010, Gallagher made an ISR quotation submission to Allianz. The broker submitted the Vero survey, together with Sphere’s responses to Vero’s recommendations. In June 2010, the ARCA Team at Allianz prepared a report following a desktop review. Sphere’s activities were classified as “Pharmaceutical and Medicinal Product Manufacturing”, being ANZSIC Code 25430, with Fire Hazard Index 6. The ANZSIC Code came from the Australian Bureau of Statistics and its New Zealand counterpart’s publication, Australian and New Zealand Standard Industrial Classification 1993 (ANZSIC).
Allianz provided ISR cover to Sphere from 2012, underwritten by Allianz’s NSW branch. On 21 January 2013, a Senior Risk Consultant in the ARCA Team, John Leehy, inspected Sphere’s premises and prepared an “ARCA – Multi-Line Report”. As Mr Iordanou explained it, by visiting risk addresses and reporting on the risks and hazards identified, underwriters were able to make informed decisions about whether to accept risks and apply appropriate weightings of premiums. ARCA – Multi-Line Reports were not provided to insureds.
In Mr Leehy’s “ARCA – Multi-Line Report”, the ANZSIC Code remained 25430 and the Hazard Index for Property remained 6. When addressing “Risk Description”, Mr Leehy noted:
“Dangerous Goods:
Dangerous goods consist of:
- 4 x 1000 litre ICB's held within an externally located approved bunded storage compound. The ethanol is pumped from the ICB to smaller 80 litre capacity tanks located within the soft gel capsule manufacturing area. The dosage is strictly controlled via solenoid valves. …
… Overall storage and handling procedures are considered to be adequate.”
Mr Leehy proceeded to describe the fire protection on site, noting that the insured should consider installing a complete automatic fire detection system. He noted that there were no sprinklers or other automatic fire protection systems at the facility. Overall, Mr Leehy considered, “This is a well managed risk. Management displayed a positive approach to loss control procedures and practices.”
Mr Leehy also prepared Risk Improvement Recommendations (RIR**s). RIRs were shared with the insureds, advising on steps which could be taken to improve a risk rating and remove hazards. If the insured made the changes recommended in the RIRs, then some of the negative loadings in ARCA’s assessment may be removed in a later ARCA assessment. The adjustment to loadings would then be taken into account by the underwriter when pricing the risk. Much of Mr Leehy’s RIRs for the Sphere site related to fire protection measures. Mr Leehy strongly recommended installation of an automatic fire detection system throughout the premises.
Allianz renewed Sphere’s ISR policy in 2013, 2014 and 2015. In October 2015, Mr Iordanou was tasked with inspecting the Moorebank site again and preparing another ARCA – Multi-Line Report. He prepared for the inspection by reviewing ARCA’s records for the risk, including Vero’s 2008 survey, the ARCA desktop review of 2010 and Mr Leehy’s ARCA – Multi-Line Report of 2013. Mr Iordanou took a copy of Mr Leehy’s report, to which he added handwritten notes during his inspection.
On 7 December 2015, Mr Iordanou inspected Sphere’s premises. Mr Iordanou reviewed the operations and processes in use in the premises. He noted that Sphere was manufacturing soft gel capsules, baby milk powder and similar items for the local market and to ship overseas. He considered fire protection at the premises. His risk field notes record that storage included “Ethanol IBCs + D[illegible], flammable and corrosive cabinets.” Management controls in respect of hazardous materials included “Ethanol – bund container”. Mr Iordanou went through Mr Leehy’s RIRs and made handwritten notes of his observations in respect of each recommendation.
On 31 December 2015, Mr Iordanou issued an ARCA – Multi-Line Report. He noted “The risk remains essentially unchanged, other than for minor improvements”. Mr Iordanou reproduced the risk description from Mr Leehy’s 2013 report, including in respect of “Dangerous Goods”: see [49]. Mr Iordanou prepared RIRs. Recommendations were made in respect of fire doors, fire protection equipment servicing, fire protection equipment obstruction, hydrant water supply flow testing, fire protection system impairment procedures and the like.
Mr Iordanou also produced a Property Risk Acceptance and Rating Guide, which assessed the Fire Hazard Index at 6 and assessed the risk as 10% worse than the Allianz Quality Standard (AQS). Mr Iordanou explained that this rating was primarily due to the issues he had raised in the RIRs. The rating was automatically generated by ARCA’s database, based on his answers to questions in a standard format report. The higher the risk, the higher the loading applied by underwriters, assuming that the risk was acceptable and not declined. If the rating was 40% to 69% worse than the AQS, the risk was “Special referral”, that is, the underwriting authority was elevated. When a risk was assessed at 70% more than the AQS, the risk loading levels recommended decline.
On 30 May 2016, Allianz underwriters considered renewal of the policy. According to Teamworks notes, the underwriter noted that a survey was completed in December 2015. The broker had advised that RIRs had been completed, “awaiting written response”. The ARCA survey noted a 10% loading. The underwriter noted, “Held for 5 years, without loss”. The underwriter noted that the client’s products were mainly veterinary products, “… mainly lotions and creams, soft gel capsules and some tablets.” Fire protection measures were noted as was the separate external hazardous goods storage for gases. The underwriter escalated the matter to, ultimately, Mr Pocknee. Allianz renewed the ISR policy.
In May 2017, Sphere’s policy was approaching renewal. On 25 May 2017, Sphere completed the RIRs prepared by Mr Iordanou in December 2015, noting the measures taken to implement each recommendation. On 25 May 2017, Mr Iordanou completed a Property Risk Assessment and Rating Guide following Sphere’s response to the RIRs, noting that the risk was now considered to be the same as the AQS. He noted, however, that some of his recommendations had not been completed. Mr Iordanou called this an RIR Review, updating ARCA – Multi-Line Reports and Property Risk Acceptance and Rating Guides based on responses received from insureds.
On 31 May 2017, an Allianz underwriter reviewed the policy for renewal. The note was detailed, “noting the broker has declared multiple customers and suppliers…”. The underwriter concluded, “NIL claims with [Allianz] since inception in 2012. Over all a well managed and quality risk”. The underwriter considered fire risk, noting that the products made were “[m]ostly non-combustible construction (<10%) EPS” and referring to the fire protection measures. According to Teamworks, the matter was referred up to three more senior underwriters, given the level of underwriting authority required. On 15 June 2017, the policy was renewed.
In May 2018, the ISR policy was due for renewal. Allianz underwriters adopted the notes made by the underwriter the previous year, noting that there remained nil claims. In June 2018, Allianz renewed the policy. In June 2019, renewal came around again. On 11 June 2019, Sphere’s senior engineer, Andrew Hall, completed Mr Iordanou’s RIRs of December 2015, setting out with measures taken by Sphere in response to those recommendations.
By now, Sphere had changed its insurance broker to the WA broker, which was an authorised representative of Austral Insurance Brokers Pty Ltd trading as Austral Risk Services. As the location of the broker affected the branch of Allianz that dealt with the policy, Allianz’ WA branch now dealt with renewal. On 6 August 2019, an underwriter followed up the WA broker in respect of the outstanding RIRs, asking that the document be completed in full as soon as possible. On 3 September 2019, the underwriter followed up the WA broker again.
But Sphere had gone into administration. On 3 October 2019, the WA broker informed Allianz that the administrators wished to cancel the policy. Allianz obliged. The administrators obtained insurance for Sphere though their broker, Gallagher, including an ISR policy with QBE Insurance.
On 4 December 2019, Sphere and deed administrators, KPMG, executed a DOCA under which GMP would acquire all of the issued shares in Sphere. An Interim Management Deed was also executed by GMP (as the Manager) and Sphere. In short, while the DOCA was on foot, Sphere would continue to own the Business Assets but GMP “will have the right to benefit from the economic rewards, and will bear the economic risks, accruing from the Business…”: cl 4.1. Business meant the business carried on by Sphere “…of manufacturing complementary health care products and infant formula”: cl 1.
On 9 December 2019, a Shared Services Agreement was entered into between Aunew and GMP. Another Shared Services Agreement was executed by Aunew and Sphere on 14 April 2021 (that is, after the fire) but with an effective date of 9 December 2019. The Shared Services Agreements were in, essentially, the same terms. GMP and Sphere appointed Aunew to provide services for a fee. The significance of the latterly prepared document is that Sphere was to receive more limited services; while Aunew was to provide purchasing and procurement services to GMP, such services were not to be provided to Sphere.
One of the Management Services to be provided by GMP under the Interim Management Deed was effecting and maintaining all necessary and appropriate insurances: cl 5.1(f). On 2 January 2020, Aunew’s Asset Management Coordinator, Mr Zeng, embarked upon this task, liaising with GMP’s Group Deputy General Manager, Lakvinder (Lucky) Singh, to arrange machinery breakdown insurance for Sphere. Mr Singh ran the Moorebank site.
Aunew also began to look for insurance for the corporate group including Sphere. Aunew dealt with three brokers, being Aon, the WA broker and the NSW broker. WeChat messages passed between Aunew’s Deputy General Manager, Mr Yin, and Mr Zeng on 30 January 2020, circulating a spreadsheet with claims data for Aon. According to their WeChat messages, Mr Zeng was working on a probation period and learning about insurance from Mr Yin.
On 21 January 2020, the Director of Human Biosecurity listed ‘human coronavirus with pandemic potential’ as a “listed human disease” under the s 42 of the Biosecurity Act 2015 (Cth), indicating that the disease may be communicable and cause significant harm to human health: Biosecurity (Listed Human Diseases) Amendment Determination 2020.
The first mention of hand sanitiser in this case is on 31 January 2020. A sales manager from a plastic bottle manufacturer emailed GMP procurement officer, Alex Yu, in respect of “Hand Sanitiser Bottles”. A spreadsheet, “GMP Hand Sanitiser Project.xlsx” was attached. The sales manager advised that he would confirm “best start dates shortly” for the project. At the same time, GMP Head of Procurement – ANZ, Noelle Wong, emailed supplier Wilmar BioEthanol in respect of “Ethanol 95–96%”:
“… As discussed we are looking for ethanol 95–96% for delivery to Sphere Healthcare as we will be making hand sanitiser gel.
Can you please advise if you have [stock on hand] for 200MT?”
Ms Wong then emailed Sphere staff, copied to Mr Singh and GMP’s R&D Manager – ANZ**,** Mallikarjun Chitneni, “We are looking to buy Ethanol into Sphere, can you please advise if you have a permit … from the ATO … for this material and for what annual quantities are we allowed to buy? Please let me know ASAP”.
On 3 February 2020, Wilmar BioEthanol emailed Ms Wong, “Is this still something you’re looking at?”. Ms Wong did not immediately reply. Rather, emails passed between New Product Development (NPD) Chemist at Sphere, Surendra Alla, GMP’s R&D Manager ANZ**,** Mr Chitneni, and Head of Procurement – ANZ, Ms Wong, entitled “**Priority** Hand Sanitiser Project # 9234”. The NPD Chemist sought technical documentation and samples for various ingredients, noting “This is top priority for Daniel”. (Presumably, this was GMP’s Daniel Xu.) Sphere NPD procurement officer, Raiz Galeon, advised, “I called supplier and sent an email, taking action as urgent”. On 4 February 2020, Mr Galeon reported that samples were on the way.
On 4 and 5 February 2020, Mr Zeng communicated with the NSW broker and the WA broker in relation to insurance. On 6 February 2020, Mr Yin asked the NSW broker whether insurance premiums would be cheaper if Sphere’s business and property was split from other GMP businesses and properties. The NSW broker said they would look into it. On 7 February 2020, the NSW broker provided an indicative quote.
On 10 February 2020, Mr Zeng sought further details of the proposal from the NSW broker, including sub-limits, excess and broker fees “for us to make an overall comparison across all brokers.” Mr Yin also emailed all managers in the business, “At present, we are conducting all insurance review for renewals at the moment aiming to improve our terms and conditions to achieve better values for all our group of companies.” Managers were asked to direct insurance inquiries to Mr Zeng. Noteworthy, Mr Cai and Mr Singh were amongst the addressees.
On 12 February 2020, Ms Wong finally replied to Wilmar BioEthanol’s enquiry as to whether the delivery of a large quantity of ethanol was “still something you’re looking at?”, advising “Yes, we are still looking at this. Our R&D team are finalising the formula for customer approval, will let you know shortly.”
Mr Zeng continued to liaison with Aon and the NSW broker in respect of insurance. Aon wanted a lot of information and there was some reluctance to provide it, with Aunew suggesting on 24 February 2020 that “these policies will go to other brokers”.
On 27 February 2020, the NSW Government issued a media release from the Minister for Health, urging the community to help prevent Coronavirus.
On 28 February 2020, Mr Zeng provided Mr Yin with a summary of renewal proposals from the three brokers. Later that day, Mr Zeng provided the WA broker with a letter of appointment. The letter was signed by Mr Yin as Deputy General Manager of Aunew. It is relevant to the broker’s later authority to cancel policies to set out some of this letter:
“We hereby appoint [WA broker] as our Insurance Broker effective from the date shown in this letter and continuing until such time as it is revoked in writing.
This appointment includes Industrial Special Risks …
Services to be provided include:
• Advising in matters relating to risk identification and transfer; …
• Negotiating policy coverage, policy renewal, policy changes and cancellations; …
This letter rescinds any prior broker appointment with effect from the date shown above …
Privacy and Confidentiality
When arranging the above transfers, all Insurers are advised that they may advise our outgoing insurance broker of the fact that we have appointed a replacement insurance broker…”
On 3 March 2020, the WA broker emailed Wendel Titus, a senior account manager in Allianz’s WA branch, attaching an ISR Quote Slip for GMP and the completed RIRs, “All other files should be in your system. Please let me know if you need anything else.” The attached quote slip noted that the insured would comprise ten entities “including auxiliary organisations”, including Sphere. Cover was to commence in March 2020. The business of the insured was described as “Principally products & health foods contracted manufacturer & wholesaler”. Claims history was noted as nil. The activity at Moorebank was described as “Manufacture of health care and milk powder products.”
An underwriter in Allianz’s WA branch, Mr Keuneman, was asked to “… have a look at this one. We held this account back in June last year. All survey rec[ommendations] have been completed as per the attached. No ch[an]ge in occupation”. Mr Keuneman had only worked for Allianz for two months and had a limited underwriting licence at the time. If a risk was outside the scope of his licence, then Mr Keuneman made an assessment and provided a summary and recommendations to Ms Lobo, who was the most senior property underwriter in Allianz’s WA branch.
Mr Keuneman commenced the qualification and underwriting process, which involved reviewing the information provided, submitting a request for an ARCA RIR Review and completing an underwriting escalation to Ms Lobo. The Vero survey and ARCA – Multi-Line Reports on the Teamworks file indicated to Mr Keuneman that up to 4,000 L of flammable liquids could be stored on the premises. As this was part of the risk identified by the ARCA risk engineers and commented on in the surveys, he was comfortable that this risk was acceptable.
As the insureds pointed out, that was not precisely what the reports said. More accurately, the reports indicated that that was how much Sphere had been storing historically, not the maximum amount that it could store. Either way, it appears that Mr Keuneman proceeded on the basis that that was the amount of flammable liquids that would be stored during the period of insurance.
Mr Keuneman made a note on Teamworks, “We held this business previously prior to the business going into liquidation, the old business – Sphere Healthcare Pty [Ltd] has been purchased by GMP Pharmaceuticals and requires cover as a new entity.” Mr Keuneman asked Mr Titus to work with the WA broker to amend the quote and advise on certain matters including:
“2. With insured entities; I don’t want to be picking up any other exposure so can you request her to review the insured business listed on the slip and only place on their relevant business specific to this exposure i.e. Sphere Healthcare Pty Ltd.
… RIR are being reviewed by ARCA I will let you know feedback once completed.”
“Sphere Healthcare has been acquired 100% by Insured and became a subsidiary. There is no previous directors on board. And there is no past exposure.”
On Tuesday, 10 March 2020, a document was created at Sphere entitled “Sphere R&D Trial Setup” for “Hand Sanitiser”. Sphere’s NPD Chemist, Mr Alla, forwarded two product disclosure statements to Mr Cai at GMP in respect of “** Priority ** Hand Sanitizer project # 9234”. Mr Cai was aware that ethanol was the primary ingredient in the manufacture of hand sanitiser.
On Wednesday, 11 March 2020, Sphere procurement officer, Vishnu Nair, emailed Mr Cai regarding “Alcohol Purchase 2020”. Details were given of “the only purchase we have done this year”, including 1,600 kg of Alcohol 95SG (standard grade) from Wilmar BioEthanol. That is, Sphere was working out how much of the 260,000 L of alcohol that it was permitted to receive had been ordered and, thus, how much it could now order. Sphere senior procurement officer, Ali Mufaddal, then promptly emailed Wilmar BioEthanol:
“We need extra stock for Alcohol for our upcoming production plan.
Can you please advise what is the maximum alcohol can you supply monthly.
Our quota for alcohol are: … 260000L/year for manufacture use…”
“We need 35000 ltr of Alcohol in the month of April 2020.
Can [you] spare this for us?”
An email in the same terms was also sent to Wilmar BioEthanol. So far as the evidence reveals, Thermo Fisher did not reply. Wilmar BioEthanol replied that Sphere’s enquiry had been sent to the account manager for advice. Mr Mufaddal promptly emailed again, asking for the account manager’s contact details, “Our GM wants to speak to him urgently.” The account manager’s mobile phone number was provided.
The amount of ethanol sought from suppliers was needed to fill an order from GMP’s first customer, JBX Pty Ltd, which was interested in acquiring hand sanitiser with a view to marketing and on-selling the product. In parallel, emails passed between GMP marketing officer, Kelly Zhang, and JBX in respect of “Hand Sanitizer Label Content”. Emails canvassed the precise ingredients that GMP would be using and its implications for the label. Ms Zhang advised that GMP used triethylamine, which was “absolutely safe to use in hand sanitiser”. JBX disagreed and requested another ingredient. By the end of the business day, Ms Zhang advised JBX, “I have confirmed with R&D team that we can change” to the ingredient suggested by JBX.
Labtek enquired whether Sphere needed denatured or un-denatured alcohol. Mr Mufaddal replied, “We need alcohol for production of hand sanitiser.” Labtek enquired what type of ethanol Sphere was using at the moment. On the procurement officer’s reply, Labtek advised, “Largest size we can do is 20L. Any chance you could take a smaller quantity than 35,000L”.
On Thursday, 12 March 2020, JBX and Ms Zhang continued to communicate on the product label for hand sanitiser, arguing about the implications of the TGA’s regulations. Ms Zhang then emailed her GMP colleagues, Mr Singh, Mr Cai, GMP procurement officer Mr Yu, Mr Xu and R&D Manager ANZ, Mr Chitneni, in respect of “JBX Hand Sanitiser Process”, setting out the formulation, label, packaging size, bottle, pump, order quantity and quotation for JBX Hand Sanitiser “so that we can be on the same page …” Ms Zhang noted “R&D has confirmed” that the change in formulation requested by JBX was okay. The label content had been updated accordingly and sent to JBX. The packaging size was 500 ml and the bottle size was confirmed, “waiting for supplier reply”. The pump supplier was in China “and lead time will be bottleneck”. The first order of 50,000 bottles was confirmed, “Also JBX requests 40 bottle samples. No label required and we can use any bottles we have on hand.”
Mr Singh asked Mr Cai to “… prepare a small trial run to test all equipment to handle sanitizer. We also need to plan deliver of Alcohol and bottles from supplier.” Procurement officer, Mr Yu, advised that a sample white bottle was ready for collection. Mr Singh’s assistant arranged collection.
On Friday, 13 March 2020, Sphere’s senior accountant, Robert Sori, emailed Mr Cai and Mr Singh, attaching Quote No. 9234 to make hand sanitiser for GMP. The quote was for 5,000 units of 500 ml. The batch run required 1,842.23 kg (or 2,280 L) of Alcohol 95SG. Mr Cai replied that the brief for Quote No. 9234 had now been finalised for raw materials and a few minor changes had been made, “Please send us the costing based on our discussion about the estimated price for bottles, pumps, label and shipper.” Mr Sori provided an updated costing.
Meanwhile, Chem-Supply advised Sphere’s procurement officer, Mr Mufaddal, that it was unable to assist with the bulk supply of ethanol. Mr Mufaddal emailed Wilmar BioEthanol again, regarding “Urgent Enquiry: Alcohol” with high importance, repeating that 35,000 L of alcohol was needed in April 2020. Wilmar BioEthanol promptly replied, “We are on allocation on ethanol now. We are looking at import options to cover supply.” Mr Mufaddal pressed (on a Friday) for 5,000 L by Monday or Tuesday, advising that he was placing orders now for Alcohol 95SG, “Please advise when we can have the balance stock. We need 35000ltrs in total.” The supplier asked to speak about “pack type”.
Ms Zhang then advised her GMP colleagues, Mr Singh, Mr Cai, Mr Yu, Mr Xu and Mr Chitneni, that the JBX quotation had been confirmed “and order quantity has been increased to 100k bottles”. Ms Zhang added that she would send an account application form “asap”, presumably to JBX. Likely at this time, GMP provided an (undated) quotation for JBX for “Hand Sanitiser 500ml”, to be manufactured on Sphere’s site. Where ethanol comprised some 75% of hand sanitiser (according to a later email from Ms Dong), JBX’s order required 37,500 L of ethanol.
Shortly afterwards, Sphere’s procurement officer, Mr Mufaddal, emailed Wilmar BioEthanol, apparently having spoken about “pack type”, advising “Plastic IBC is fine too. Please secure 35000ltrs for us and I will let you know the split deliver dates. Please advise the price too. We need to communicate this to our customer today.” Mr Mufaddal appears to have had in mind to take delivery of the 35,000 L by split deliveries, that is, in instalments. Presumably, this was because he appreciated that Sphere’s dangerous goods area did not have capacity to store 35,000 L of ethanol all at once: see also [140].
The supplier replied that they were getting confirmation but, “I think it should be OK. 35000L in April. Please ensure that everyone internally is aware that ethanol is on allocation for any other orders.” The price for 95SG 1000 L HDPE IBC’s was $1.82 a litre. That evening, GMP’s procurement officer, Mr Yu, circulated a quote for the pump to his colleagues, Ms Zhang, Mr Singh, Mr Cai, Mr Xu and Mr Chitneni, advising that the earliest completed date was about 20 April 2020, “I’m still working with supplier to check if they deliver us 100K first”.
On Sunday, 15 March 2020, the NSW Government issued a media release, announcing that special state powers had been triggered to combat COVID-19.
Problems were being experienced by the WA broker in securing insurance for the Aunew group. Given the limited time remaining to secure insurance cover, the WA broker proposed that the Moorebank site be insured separately with Allianz, given the relatively low risk of the location and its nil claims history.
On Monday, 16 March 2020, Sphere’s procurement officer Mr Mufaddal informed Mr Cai, Mr Singh and Sphere’s Procurement Manager, Monica Halligan, that he had been able to secure 35,000 L from Wilmar BioEthanol in April 2020. But according to a later email from the supplier, Sphere did not place this order as “Sphere didn’t know at that stage how they were going to manage the ethanol onsite”: see [140].
Meanwhile, Mr Iordanou was asked to prepare an RIR Review, commenting on the measures taken by Sphere in response to his recommendations made in December 2015. On 16 March 2020, Mr Iordanou produced an ARCA – Multi-Line Report. The ANZSIC Code remained 25430, with a Hazard Index for Property of 6. Mr Iordanou also completed a Property Risk Acceptance and Rating Guide for the Moorebank site. There had been nil claims in the last three years. The RIRs had been completed except for one: there were no hydrant flow test results for review. The steps taken by Sphere had improved the risk to 20% better than the AQS.
The WA broker’s difficulties prompted Mr Zeng and Mr Yin to re-consider other brokers. Later on 16 March 2020, Mr Zeng emailed Mr Yin, attaching an updated comparison of the quotes obtained by the three brokers for ISR policies. Mr Zeng emailed the NSW broker, copied to Mr Yin, enquiring whether they could change their broker 20-days past renewal, where most of the certificates of currency and policy schedules had been issued. The NSW broker assured them that they could.
On Tuesday, 17 March 2020, Mr Singh’s assistant emailed Sphere’s Regulatory Affairs Officer, Lena Matti, Mr Mufaddal and Mr Cai, attaching specifications of 500 ml bottles and a spreadsheet in respect of the GMP hand sanitiser project. Ms Matti was asked to create a code for hand sanitiser bottles. Mr Mufaddal was asked to contact the supplier of the bottles and issue a purchase order, being “100,000 quantity for first order”.
On Wednesday, 18 March 2020, the Governor General declared a “human biosecurity emergency” under s 475 of the Biosecurity Act in respect of human coronavirus with pandemic potential, noting that the virus was posing a severe and immediate threat to human health on a nationally significant scale: Biosecurity (Human Biosecurity Emergency) (Human Coronavirus with Pandemic Potential) Declaration 2020. The NSW Health Minister made an order under the emergency powers of the Public Health Act 2010 (NSW), banning non-essential indoor gatherings of 100 or more people, as part of national measures to curb the spread COVID-19. The minister issued a press release, encouraging the community to practice social distancing “and vigilantly practice safe hand hygiene measures moving forward.” The Prime Minister announced similar measures, including social distancing of 1.5 m.
Mr Keuneman also emailed the WA broker as follows:
“In order for me to progress with terms for GMP Pharmaceuticals (Sphere Healthcare Pty Ltd) I require the following:
- Claims histories from when the insured was placed into liquidation on 16/8/2019 up to the period they came out of the insolvency scheme. When Sphere was purchased; who was insuring the assets?
- If the insured has been uninsured for any period of time I require the dates that they were uninsured and confirmation in writing of nil claims or incidents.
3. Please confirm the*[re]* has been no change in business activity as per your slip.
- When we held this policy we were not insuring the building; whereas your slip now includes cover for the building. Can you please confirm if GMP purchased the building?
- I require your slip to be amended to note only the entities we are insuring; i.e. GMP Pharmaceuticals (Sphere Health Care Pty Ltd). Please remove all other entities and or/auxiliary organisations.
- Start date of policy - I was working toward 31/3 start date for this policy; should you require an earlier start date I would first need the above information in order to do so.” (Emphasis added.)
At the same time in Sydney, Sphere’s NPD procurement officer, Mr Galeon, emailed a supplier of lavender oil, copied to Mr Singh’s assistant, “We’re using it for Hand Sanitizer project and requires 125kgs”. An equipment supplier also emailed GMP, advising that they had a machine in stock “…and this machine is mainly designed for Alcohol gel, which is booming up due to the virus issue”. These details were forwarded to Mr Singh.
The WA broker made enquiries of Gallagher in respect of Sphere’s claims history while in administration. The WA broker passed on the information to Mr Keuneman, advising that there had been no claims. Further:
“…2. Holding cover expires on 13th March 2020. Confirm there nil claim or incident.
3. Confirm there is no change in business activity.
4&5. GMP has been Sphere Health Care’s landlord for all these years. After acquiring Sphere Health Care, GMP/Aunew is now operating instead of property owner.
- Considering the circumstances, appreciate your understanding of the urgency, as soon as you could please.” (Emphasis added.)
“…As discussed I require:
- Claims histories for period 13/12/19 to 13/3/20 (underwriter letter head) …”
Three minutes later in Sydney, Sphere’s procurement officer, Mr Mufaddal, emailed Wilmar BioEthanol again, “Can we please secure 40,000ltrs.”
Later that evening, Mr Cai emailed Mr Yin, copied to Mr Singh, in respect of “Coverage for pandemic”. Mr Cai asked, “I’m not sure if other site managers have contacted you about our insurance coverage for this pandemic.” Mr Cai set out some scenarios, including a confirmed case of Covid in the factory or a government ordered lockdown, “…what coverage (if any) we can expect and how we should be prepare (if relevant) to be eligible for this coverage.” Mr Yin advised that Mr Zeng was the person in charge of group insurance and any emails should be sent to him.
On the morning of Thursday, 19 March 2020, Wilmar BioEthanol advised Mr Mufaddal that the supplier was still not in a position to commit to the requested ethanol, “Only historical volumes.” Ms Zhang circulated artwork for JBX hand sanitiser to her colleagues for review. GMP procurement officer, Mr Yu, advised that he had received samples of the lotion pump from the supplier; the tube length needed to be tested with the bottle and, once confirmed, five samples of the bottle and pump would be sent back to the supplier for reference.
The WA broker sought the information requested by Mr Keuneman from the Aon broker in London. The WA broker passed this information to Mr Keuneman; essentially, the Aon broker did not know. The WA broker advised “I think this is as good as we could get. Client confirmed there is no claims / incidents from 13.12.19 to 19.3.20.” The WA broker also provided a letter of appointment, being the letter of 28 February 2020 referred to at [76].
That evening in Sydney, Sphere procurement officer, Mr Mufaddal, emailed Wilmar BioEthanol seeking clarification, “We are OK for 35000 ltrs for April but you cannot commit for an extra 50000ltr?” Two minutes later, Mr Mufaddal emailed Redox, requesting quotes for 5,000 L and 10,000 L of Alcohol 95SG for April delivery. Later that evening, Wilmar BioEthanol replied to Mr Mufaddal, “It is changing daily. On 13th it was potential. We have been talking about it for over a month.”
Later still in Perth, Mr Keuneman emailed Allianz’s head office, advising that he was close to formalising terms on Sphere, but sought feedback on survey requirements. The survey on file was completed in December 2015 and was current until December 2020, at which point the insurer would need to resurvey, “Can you please advise what ATS/ARCA’s position would be on this given the Corona virus impact.” (ATS was a specialist team of underwriters with a high level underwriting authority, then categorised as level 5.) Mr Keuneman provided a summary of the proposed policy for the Moorebank site and details of the current survey and RIR Review. In particular:
“GENERAL DESCRIPTION AND OCCUPATION: Manufacture and Distribution of natural and nutritional pharmaceutical products including coating of tablets, extraction of liquids from vegetation, liquid herbal extracts …”
But in Sydney, Aunew was continuing to seek cheaper insurance through the NSW broker. On Friday, 20 March 2020, Mr Yin emailed the NSW broker, pressing for the best price, “Please try any good strategies to get us a good package deal”.
In Perth, Mr Keuneman emailed the WA broker, asking that entities unrelated to the Moorebank site be moved from the slip. Once an adjusted slip was to hand, Mr Keuneman would be “…ready to firm up terms with policy inception as at today 20/3/20.” The WA broker promptly obliged. Mr Keuneman updated Teamworks, noting that Allianz had insured this business previously from 2012 to 2019. The policy was cancelled as the insured went into voluntary liquidation at which point insurance was covered under an insolvency scheme. Mr Keuneman noted that GMP purchased Sphere Healthcare in October 2019.
Meanwhile in Sydney, Mr Mufaddal followed up Redox, “We need the stock in April.” He then emailed again the following day, “We need 45 tons alcohol. … please see what you can do. Delivery in April”. At 3.26 pm, Redox replied, “We are currently on allocation and not able to purchase any extra stock at this stage. As you can understand due to the current situation [the] producer [has] sold out”. Redox enquired, “Are you making hand sanitiser with this or is it used for something else?” Mr Mufaddal replied, “Just sanitisers.”
In Perth, the WA broker emailed Mr Keuneman, attaching an updated quote slip for the Moorebank premises with a limit of liability of $26.8 million. Mr Keuneman updated the Teamworks notes.
Back in Sydney, Sphere Operations Manager, Tina Dong, emailed her colleagues regarding “hand sanitiser manufacturing and filling” as follows:
“We will make hand sanitiser product with 50,000 L (100,000 units, 500 ml). The ethanol concentration for this product is 75%. I had a look at the process … yesterday.”
Various things needed to be organised, “We may start a trial batch at the end of March”. In particular, Sphere’s Engineer Supervisor, Brett Edwards, was asked to “remove a few power points in the liquid manufacture room to ensure the area is explosion proof as the ethanol concentration is 75% for this product”.
Back in Perth, Mr Keuneman escalated the proposed policy to Ms Lobo, as it was outside his underwriting authority level. Ms Lobo approved the policy, making a comment on Teamworks:
“… Underwriting approved noting that the broker/client has confirmed that there is no change in business activities from when Allianz previously held this policy. Please make term subject to risk survey being completed within 30 days of inception of cover and any risk recommendations resulting from the survey to be completed within 45 days of survey.”
Ms Lobo agreed that she instructed Mr Keuneman to proceed in this way as she knew that there had been no survey of the premises for over four years and no survey since the company had been through administration. Ms Lobo and Mr Keuneman rejected the suggestion that commercial considerations were a factor in the underwriting decision, such as the fact that Allianz had insured this risk for many years or that the placing broker provided a large amount of business with Allianz. Ms Lobo said “it’s more to do with underwriting the risk itself”, and, while commercial considerations may affect pricing, it would not affect “the actual acceptance of the risk”. I accept their evidence.
Mr Keuneman updated the Teamworks notes. Mr Keuneman then emailed the WA broker, attaching new business terms for Sphere / GMP and corresponding wording, “Looking forward to receiving bind instruction at your earliest.” Attached was an ISR quotation and Austbrokers ISR policy wording Mark IV Modified. (Ms Lobo was not aware that Mr Keuneman did not implement the condition she had noted on Teamworks when the quote was sent out.) The named insureds were Aunew, GMP, Sphere, Sphere Holding Company Pty Ltd and Tabco Pty Ltd.
Two minutes later, Mr Yin and Mr Zeng received an email from the NSW broker, updating them on progress, “We are still waiting for insurers to re-quote. When [the NSW broker] is appointed the broker, we shall be able to negotiate with the insurers for better coverage. … I look forward to receiving the Broker Letter of Appointment.” The insurance package put forward by the NSW broker included the Moorebank site.
Back in Perth, and presumably unaware that Aunew was continuing to shop around, the WA broker emailed Mr Keuneman at 7.22 pm, “Please bind as quoted. Closing to follow shortly.” Mr Keuneman replied, “confirming cover in place eff[ective] 20/3/20.” There is no dispute that a contract of insurance came into existence on 20 March 2020.
Later that evening, the WA broker emailed Mr Yin and Mr Zeng, attaching “complete document package for your attention”. Attached was a 7.95MB zip file entitled “GMP - Complete doc pack.zip”. The WA broker advised that they would “provide full insurance manual shortly.” Likely, this material included the policy schedule and policy wording for the ISR policy.
On Saturday, 21 March 2020, Mr Yin and Mr Zeng continued to exchange WeChat messages discussing the WA and NSW’s brokers competing offerings. They proposed to “fully follow” some policies arranged by the WA broker, including for the Moorebank site, and then use the NSW broker to arrange other policies, “This way, the total cost is still much lower than the current [WA broker] pricing.” But the policies arranged by the NSW broker “cannot be backdated”. Nor did they want to pay “broker fees twice”. It was decided to appoint the NSW broker on receiving confirmation that the policies arranged by the WA broker “will remain unchanged after [the NSW broker] takes over, and we won’t be double charged.”
On Monday, 23 March 2020, the NSW Premier advised that, from midday, essential activities and businesses would be temporarily shut down. Parents were encouraged to keep their children at home from school.
Also on 23 March 2020, the NSW broker emailed Mr Zeng and Mr Yin, “In order … to take over some of the policies”, the NSW broker recommended that its appointment be backdated to 29 February 2020. Mr Zeng was asked to photocopy a letter onto Aunew’s letterhead and to sign and return the document that day. In respect of the policy for the Moorebank site, the NSW broker noted “to take over, premium amended”. The broker offered to “assist with the paperwork on the few policies we are taking over.”
Some of the premiums in the NSW broker’s email were in blue font. WeChat messages passed between Mr Yin and Mr Zeng, noting that the items marked in blue were “the policies copied from [the WA broker]”, that is, four of the policies arranged by the WA broker “are takeovers … Technically they can all be cancelled, but since some of [WA broker’s] policies are done well, we can continue with them. There is no need to cancel”. Mr Zeng signed the letter of appointment for the NSW broker. He back-dated the letter but to 28 February 2020, not 29 February 2020.
WeChat messages continued between Mr Yin and Mr Zeng as to when and how to tell the WA broker. They discussed whether they should offer to pay part of the broker fee, having been advised by the NSW broker that they could refuse to pay because the WA broker had “broke[n] their word”. Mr Yin suggested, “Tell them they’ve left us no choice but to try someone else because their price has increased several times and neither of us can justify it to our boss. Tell them Gerry is not in the mood to talk to them anymore. He can’t face the boss … [As for broker’s fees] just say we won’t pay for now”.
Soon afterwards, Sphere’s Procurement Manager, Ms Halligan, emailed Wilmar BioEthanol, asking the person with whom they had dealt to this point to “provide your boss’s name and number”. The account manager obliged and also advised that Sphere currently had no allocation due to its account being closed in 2019 and all volume being taken out of the budget for 2020. The account manager acknowledged that it was “awkward timing” and he had been trying to help but, as time had moved on, his ability to do so decreased significantly. Further, with the sheer amount of work currently, there was not enough time to get back to customers on what their plans were.
Soon after this, Mr Yin and Mr Zeng spoke to the WA broker, afterwards communicating on WeChat, “The way we teamed up in talking with [the WA broker] today was great, leaving them nothing to say”. Apparently Mr Zeng was less convinced, “For now they look okay saying they’ll give up AUD 30,000 commission”.
Moments later, at 6pm on 23 March 2020, Mr Cai emailed Sphere Head of Quality, Mark Peiris, and Ms Halligan, copied to Mr Singh, Mr Mufaddal and Mr Chitneni regarding “Alcohol import”:
“We face shortage of alcohol Australia wide and we urgently need alcohol not only for products but also to support daily operations.
Is there possibility to import alcohol from China? If so how to operate? Does our permit allow imported alcohol?
I managed to negotiate with some Chinese supplier who supply food grade 95% alcohol, just need suggestions and advice to see if we actually can do this.
As you may know that everyone is chasing for alcohol, so if I cannot secure it quickly we might end up with nothing which will be a disaster.
Please look into this and advise from both regulation and logistic point of views as soon as possible.” (Emphasis added.)
GMP’s R&D Manager – ANZ, Mr Chitneni replied to Mr Cai’s email, “Take into consideration this to be a dangerous good (highly flammable)”.
On Tuesday, 24 March 2020, Mr Peiris replied to Mr Cai, advising that there was no problem using imported ethanol from a “QA” point of view.
Also that morning, the NSW broker emailed Allianz’s Melbourne branch, advising that the broker was to handle insurance for the Moorebank site. The (backdated) letter of appointment was attached. The NSW broker looked “forward to receiving your confirmation of transfer and policy documents.” Allianz account manager, Pravin Udayakumar, forwarded the letter to Allianz’s Melbourne distribution manager, Clinton Vonow, for approval. Mr Vonow liaised between brokers that sent business to Allianz and its underwriting team.
At the same time, Mr Singh called Auckland company, Fonterra Co-operative Group Ltd, seeking supply of ethanol in Australia for sanitiser. Fonterra advised Mr Singh “…our supply is constrained right now and with very heavy demand due to increase in hand sanitizer sales.” The demand for ethanol for hand sanitiser manufacture was being coordinated by Fonterra’s distributor, whose contact details were supplied.
Separately, Ms Halligan made a complaint to Wilmar BioEthanol, expressing her disappointment and frustration at how the supplier had handled the situation, but concluding “…all [I] want to know is if there is any material … so as a business we can move forward.” Mr Singh then forwarded his emails with Fonterra to Ms Halligan, who replied, “Let me see what they have.”
Soon afterwards, Wilmar BioEthanol responded to Ms Halligan’s complaint. The supplier was unmoved, noting that it would have been able to supply 30,000 L when first asked, “however this was changing daily”. Further:
“If I received an order that day I could have had it processed. We were not on allocation at that stage. However Sphere didn’t know at that stage how they were going to manage the ethanol on site.” (Emphasis added.)
Wilmar BioEthanol also noted that Sphere’s volume requirement continued to change, “…these talks originally started earlier, and had dragged on for 4 weeks, with nothing conclusive from Sphere.” The account manager had made time to meet with the Sphere’s procurement officer to discuss requirements, but the meeting was cancelled. Ms Halligan rejoined that the meeting had been cancelled due to the COVID-19 outbreak and an internal directive not to have suppliers on site. Ms Halligan pressed, “please let me know if there is any material … so as a business we can move forward.”
Mr Cai provided GMP’s R&D Manager ANZ, Mr Chitneni, with specifications for alternative ingredients which could be used to make JBX’s sanitiser, noting that the customer “has stopped printing out more labels”. The email was copied to Mr Singh, Ms Zhang and Sphere’s NPD Chemist, Mr Alla. Mr Chitneni was asked to advise the impact of the alternative ingredient on the label “… and adjust formulation as soon as possible so that [the] customer can print new labels.” Mr Alla was asked to update the brief once the formulation was updated, “we need to recost it”.
Further emails passed between Redox, Ms Halligan and Mr Singh, with specifications for another ethanol product, Ethanol 94. Ms Halligan clarified to Mr Singh, “Specification for Alcohol for Hand Sanitizer ONLY”. Mr Singh sought confirmation “… if we can use for hand sanitizer.” Mr Chitneni confirmed, “It’s all good to be used in a hand sanitiser … ask Redox to remove the Methanol from the report, just to avoid panic”. Mr Singh forwarded this confirmation to Ms Halligan and Mr Mufaddal.
By now, Allianz’s Melbourne distribution manager was concerned about the letter of appointment received from the NSW broker. Mr Vonow emailed the account manager, Mr Udayakumar, copied to Mr Keuneman and Mr Titus in Perth, “There are some concerns over this [letter of appointment] as it looks as though we received another [letter of appointment] for a WA broker signed by a different party (same insured) and on the same day.” Mr Udayakumar was asked to seek more details from the NSW broker without disclosing the name of the WA broker.
News of this reached Mr Zeng and Mr Yin, with WeChat messages immediately passing on this subject, together with a copy of the letter of appointment, “The date is 28th Feb, same as the one we gave [the WA broker] before, which means we appointed two brokers on the same day. Could this be a problem later?” Mr Yin replied, “Hold on, let me change it to the 29th”.
At 3.25 pm, the WA broker emailed Mr Yin and Mr Zeng as follows:
“… We’ve been notified by Insurers that they’ve received the [letter of appointment] from another broker. Please reply to this email to provide confirmation that we are no longer your appointed broker in order to process the cancellation.”
“Thanks for your call. As discussed, please cancel the policy."
That is, the WA broker did not wait to hear back from Aunew before informing Allianz that the ISR policy for Sphere was to be cancelled. Perhaps appreciating that they had ‘jumped the gun’, the WA broker then called Mr Yin, who messaged Mr Zeng that the WA broker “… said they’ll send you an email. Once you receive it, first check with [the NSW broker] on what it means for us and what responsibilities there are …”
At the same time, Ms Halligan asked Redox whether it was possible to remove methanol from the specifications for the substitute ingredient, given the comments of Sphere’s R&D Manager.
At 3.51 pm, Mr Zeng sought advice from the NSW broker as to how to respond to the WA broker’s email of 3.25 pm, “… from my knowledge you are taking over some of [the WA broker’s] current policies. If [the WA broker] proceed to cancel their current policies, will that affect your take-over?”
At 4.15 pm, the WA broker emailed Mr Yin as follows:
“Please see below the steps for cancellation.
- We’ve been advised by you on 23/03/2020 that we were no longer your appointed broker.
- After 24 hours cool off period, you haven’t changed your mind and we’ve been notified by Insurers that they’ve received the [letter of appointment] from another broker which indicates that you have had made the final decision.
- Hence we will need to start the cancellation process as of the end of business today. ….”
“We confirm we decided to go with another broker.”
“Confirm cancellation with effect from 24/03/2020.”
At 5.04 pm, Allianz’s Melbourne account manager emailed the NSW broker, requesting further details given the competing letters of appointment dated 28 February 2020. Allianz’s Melbourne distribution manager updated Mr Titus and Mr Keuneman in Perth, advising that they would give both brokers 48 hours to provide an updated letter of appointment. Once Allianz had confirmation of who was actually the appointed broker, then it would proceed accordingly.
At 6.06 pm, the NSW broker emailed the re-backdated letter of appointment to Allianz’s Melbourne account manager, advising that the NSW broker was “the latest appointed broker. The Policy to transfer to [the NSW broker] is BAW0001-229 869 from 20th March 2020 to 28th February 2021. We look forward to your confirmation of transfer.” At 6.15 pm, Mr Zeng and Mr Yin also sought confirmation from the NSW broker that the policies on the broker’s list “are all effective / cover in place now”. At 6.45 pm, the NSW broker advised that they had “verbal confirmation” of transfer of the Moorebank policy, “… Allianz … will formally confirm once they have internally done the transfer.”
As earlier mentioned, the WA broker was an authorised representative of Austral Risk Services. Mr Titus spoke to the managing director of Austral Risk Services. It appears that Allianz wanted an explanation. Later that evening, the managing director of Austral Risk Services emailed Mr Titus, advising that he had spoken to the WA broker. He defended their actions, noting that the WA broker had “advised the client that if they were going to seek terms elsewhere after the work they had done then it was best they go elsewhere.”
On Wednesday, 25 March 2020, emails passed between Allianz officers in Melbourne and Perth as to how to proceed “seeing the policy hasn’t been processed yet?”
On Thursday, 26 March 2020, Allianz’s Melbourne distribution manager made a note in Teamworks, “Cover bound with WA broker under BAW001-22-869. Not processed on Polisy [being a system which records the premium] and then a [letter of appointment] was received by NSW broker. Confirmed with WA that policy was taken and that the NSW broker is to proceed with cover.” The letter of appointment was attached, together with the WA broker’s quotation slip and Allianz’s quotation schedule. Mr Keuneman’s notes in respect of the WA policy were automatically reproduced.
Ms Halligan also followed up Wilmar BioEthanol for a response. The account manager replied, “At present we have no allocation in place for Sphere”.
Later that morning, Mr Vonow emailed Allianz’s Underwriting Operations Manager in Sydney, Matthew Millener, in respect of Sphere’s policy:
“… we have received an [letter of appointment] for a new business that was quoted in WA.
- Cover bound with WA broker under BAW001-22-869.
- The [new business] was never processed on Polisy.
- Cover was requested, changed to Won but no closing had been received.
- An [letter of appointment] was received by NSW broker. Confirmed with WA that policy was taken and that the NSW broker is to proceed with cover.
- I have set up a [new business] request an allocated to yourself.
- We just need the rater cloned and revised (steadfast terms) sent to the new broker.”
Mr Pan said that the account was transferred to Allianz’s NSW branch, as the NSW broker was based in that state. Meanwhile, the NSW broker asked Allianz’s Melbourne account manager for a premium breakdown on the policy, “Paperwork can follow when you have done the transfer.” Allianz’s Melbourne account manager replied that there was some delay in getting this information, “Rest assured cover is held whilst we investigate this.” Mr Millener then advised Mr Vonow that he had reviewed the letter of appointment, “All good to proceed”. Mr Pan was asked to “look after this one for us. Can you please clone the old rater, generate terms and send out to the broker.”
Mr Pan agreed that the instruction to “clone the old rater” was an instruction to copy across the rater tool created by Allianz’s WA branch when quoting and binding the cover. He was also told to use the Steadfast terms when generating terms to be sent to the NSW broker. Steadfast terms were standardised ISR terms used by brokers in the Steadfast Group when transacting business with Allianz. Mr Pan understood from this instruction that the NSW broker was affiliated with the Steadfast Group.
Mr Pan understood that he was to issue a policy on the standard Steadfast terms for the same premium on which the cover had already been bound. He was not being asked to determine if the risk ought to be accepted, as it was plain that Allianz had already bound this insurance. Mr Pan understood that he was being asked to perform the steps that were necessary to have the bound cover set up in Allianz’s NSW branch, with a new broker on record and the standard wording for that broker’s affiliated group.
Notwithstanding the limited task given to him by Allianz’s Underwriting Operations Manager, Mr Pan reviewed the underwriting to confirm the risk was acceptable. Mr Pan actually recalled looking at the documents and confirmed in cross-examination that he did read them. He became aware from his review of the Teamworks file that Allianz had provided ISR cover to Sphere from 2012, originally underwritten by Allianz’s NSW team when the broker was Gallagher. ARCA – Multi-Line Reports had been produced in 2013 (by Mr Leehy) and in 2015, 2017 and March 2020 (by Mr Iordanou). According to these reports, Mr Iordanou’s RIRs had been implemented by the insured.
Mr Pan became aware that Sphere had entered voluntary administration in 2019 and the ISR policy was then cancelled. Mr Pan noted that Mr Keuneman had sought confirmation that there had been no change in business activity, and this had been confirmed by the WA broker on 18 March 2020. Confirmation had been obtained from Gallagher and London underwriters that there had been no claims during the period of administration or since. The policy was bound on 20 March 2020 by the WA Branch under reference number BAW-001-229-869.
Mr Pan explained that some of the data in the new rater which he prepared was auto-generated and some was manually populated by himself as the underwriter. The rater he prepared resulted in a premium that was slightly higher than had been recorded by Allianz’s WA branch. In order to achieve the same premium as quoted by Allianz’s WA branch, he inserted that premium and the discount loading percentage automatically changed to accommodate the difference. But the premium was not the product of an independent underwriting process that he undertook.
Mr Pan made an entry in Teamworks that this was new business which was written by WA, “…Bound and WON. [New business] not processed on Polisy.” A letter of appointment had been received by the NSW broker. Mr Pan finalised transfer of the policy to the NSW Branch. By this, he meant there was a changeover in broker after binding and before closing.
Melbourne account manager, Mr Udayakumar, then emailed the NSW broker, “Please find attached terms.” Attached was an Allianz ISR quotation (the policy number was now BAW0001-231-488) and policy wording, being Steadfast Industrial Special Risks (Mark IV) Modified 01.13. The named insured was now just Sphere. The broker was asked to “forward your closing at your earliest convenience”. The NSW broker replied, “Appreciate your efforts in sending the documents through so promptly despite this challenging time.”
On Monday morning, 30 March 2020, Sphere’s Engineer Supervisor, Mr Edwards, emailed Sphere’s Operations Manager, Ms Dong, reporting on modifications being made to the mixing room, apparently in answer to the email of 20 March 2020 in respect of “Hand sanitiser manufacturing and filling”: see [120]. Ms Dong forwarded Mr Edwards’ estimate of the costs involved to Mr Cai and Mr Singh’s assistant, asking whether the expenditure of at least $7,000 was “fine with you”, further:
“Hi. Team
In order to manufacture ethanol based hand sanitiser, we need to modify our liquid manufacturing section to explosion proof level.”
Redox also emailed Ms Halligan a specification for ethanol 94%. Ms Halligan followed up Redox as to whether it would remove methanol from the specifications. Redox replied that it was unable to remove anything from, or add anything to, the specifications.
On 31 March 2020, the NSW broker emailed Mr Udayakumar, attaching a placing slip and closing (or tax invoice) in respect of the ISR policy for the Moorebank site. Both documents referred to the policy number arranged by the WA broker, while the sub-limits were as per the policy schedule issued by Allianz’s NSW branch. The placing slip noted that the policy wording was Allianz Steadfast POL648BA/SF ISR Mark (IV) Modified 01.13.
On 1 April 2020, Mr Pan emailed the NSW broker, thanking them for “sending through the closing” and attaching the policy schedule for their records. The policy wording was not attached. The NSW broker replied:
“…Please advise if the attached Allianz Steadfast wordings should apply to this ISR policy. If not, please email wordings.”
As I read it, the NSW broker was seeking clarification of the position, where the Steadfast wording had been referred to in the placing slip but was not attached to Mr Pan’s email. On 2 April 2020, Mr Pan confirmed that the policy wording was POL648BA/SF Steadfast Industrial Special Risks Mark IV Modified 01.13.
The contract of insurance now comprised an Allianz ISR Policy Schedule and Steadfast Industrial Special Risk Insurance (Mark IV) Modified policy document. The Policy Schedule began with a recitation of the duty of disclosure, followed by details of the parties, the policy details and the premium. The Business was described as follows:
“Principally products & health foods contracted manufacturer & wholesaler and property owners and any other activity incidental thereto. and property owners and any other activity incidental thereto.”
Limits of liability followed ($26.8 million) then sub-limits and deductibles. An Amendment Notice set out the duty of disclosure in more detail and the consequences of non-disclosure. Endorsements followed, of which three are relevant, being UNDISYB4, ALTERVS4 and ALTERXS4.
The policy document began with a recitation of the insured’s duty of disclosure under the Insurance Contracts Act, followed by indemnity clauses and exclusions. The policy document concluded with Conditions, of which three are relevant: Condition 1 (Misrepresentation and Non-Disclosure), Condition 2 (Alteration) and Condition 5 (Cancellation).
Later on 2 April 2020, Mr Singh’s assistant received an email from another Aunew company, Health Sharing Group Pty Ltd, placing an order for 10,000 bottles of 500 ml hand sanitiser, 10,000 bottles of 500 ml sanitiser spray and 10,000 bottles of 100 ml sanitiser spray. Mr Singh’s assistant advised “our correct price” was higher. By close of business, a purchase order had been received.
On 3 April 2020, a consultant emailed Mr Cai and Mr Xu, offering their services, “It was great to speak with you and Daniel just now and hear about your new production capability at the old Sphere manufacturing facility at Preston [sic] which enable you to make hand sanitiser products”. The consultant offered to assist with sourcing materials and exploring opportunities for hand sanitiser products.
Later that day, Mr Cai emailed Mr Singh with an invoice for denatured alcohol imported from China and sought authority to purchase “under special item to secure ASAP”. Mr Singh promptly replied, “Yes, please go ahead”. Sphere issued a purchase order to a vendor in Hong Kong for denatured ethanol 95% manufactured in Shanghai for 48,640 kg (or 60,198 L) at a cost of USD $94,848. A sales contract was executed between Sphere and the Hong Kong vendor the same day.
Mr Galeon also emailed Mr Singh and Sphere’s R&D Manager, Mr Chitneni, copied to Mr Cai, Ms Halligan, Mr Mufaddal, Mr Alla and Mr Singh’s assistant, providing lavender oil options from the local supplier with a view to “lock in [purchase order] on Monday.” Mr Cai also replied to the consultant, seeking their assistance to connect with more business opportunities for the sanitiser range, noting:
“We have just sourced the desired material now, our factory will have capacity in late May.
Currently we can do 100 ml – 500 ml bottles with simple design in both gel sanitiser and liquid alcohol sanitising spray products.”
On 9 April 2020, Sphere placed a further purchase order with Redox for denatured ethanol 94% for 8,800 kg (10,891 L) at $7.98 per kg. I note that local prices for ethanol had significantly increased from the $1.82 per L quoted by Wilmar BioEthanol on 13 March 2020. It was also now far more expensive than the ethanol being imported from China for USD $1.95 per kg.
On 22 April 2020, as delivery of the Chinese ethanol approached, Sphere’s warehouse team leader, Mr Urbina, emailed Mr Singh, Mr Cai and others, raising a number of concerns about the bulk delivery of ethanol. The ethanol was to be received by a tanker and stored in IBCs supplied by Redox. But the cages where flammable materials were stored were old and rusted and had not been used for a long time. Nor were there proper control measures in the case of spillage. Personnel needed to be trained to receive ethanol “as we never done it before”.
What action was taken, if any, is unknown. Mr Urbina said he was concerned about the storage facilities at the site. He considered that the premises were not equipped to store such a large volume of ethanol according to the normal safety standard of operation procedures, which required the ethanol to be contained. Nor was he consulted about the capabilities for storage of such a large volume of ethanol at the premises.
On 24 April 2020, Sphere took delivery of 8,080 kg of ethanol 94% from Redox, being 10 IBCs or 10,000 L. Mr Urbina said the IBCs were stored in steel cages within the bunded area. This probably marks the commencement of the manufacture of hand sanitiser. Mr Urbina recalled that the first few batches of hand sanitiser were produced using ethanol which was sourced locally. Sphere started producing an average of eight pallets of hand sanitiser each week. Each pallet had 40 cartons, each containing twelve 500 ml bottles of hand sanitiser.
On 5 May 2020, Sphere’s customs agent advised GMP’s procurement officer Mr Yu, Mr Cai and Mr Singh’s assistant that the ethanol arriving from China was classed as Dangerous Goods Class 3. The Dangerous Goods declaration paperwork was sought. On 6 May 2020, Sphere prepared product specifications for JBX hand sanitiser gel.
On 13 May 2020, Sphere’s customs agent advised that the ethanol from China would soon be delivered, “… over 4 semi loads [with] each delivery … at 19 pallets approx. per load”. Mr Urbina emailed Sphere’s Operations Manager, Ms Dong, “We are going to receive 80 IBCs of ethanol. W[h]ere are we going to put it”. Mr Urbina pressed that this was not only a concern for the warehouse but needed to be decided at a higher level, “I cannot take upon myself such responsibility.” Mr Urbina also mentioned his concerns at the daily site meeting.
Ms Dong emailed her team, “Can we receive 80 IBCs of ethanol?” Sphere’s Head of Quality, Mr Peiris, advised that he had had a meeting with the General Manager about this and the IBCs could be received, “The material will be used very quickly to manufacture hand sanitiser where it gets diluted. Hence the risk involved is bare minimum according to [the general manager].” Presumably, the general manager was Mr Singh. The next day, 14 May 2020, Sphere issued an order confirmation to JBX ($824,900), with delivery of hand sanitiser to begin on 10 July 2020.
On 22 May 2020, Sphere received 304 drums of denatured ethanol 95% from the Chinese supplier. The ethanol was delivered in 80 pallets, each containing four 200 L drums of ethanol. Ms Dong instructed staff to store the ethanol in the old dispatch area. Mr Urbina said management resolved that the ethanol was to be stored in this area, as it was the only area available. The plastic barrels were double-stacked. The same day, Sphere issued an invoice to JBX for the first delivery of hand sanitiser.
In June 2020, Mr Cai was promoted to Deputy General Manager with Aunew. He took over from Mr Singh. On 6 July 2020, KPMG advised that the DOCA had been wholly effectuated and the deed was terminated.
Shortly after 6 pm on 9 July 2020, a fire started at the Moorebank site. The next morning, the NSW broker notified the insurer, advising that 100 firefighters had been called; the fire had made the news. Fire and Rescue NSW’s report identified the fire origin as in the old dispatch area. Mr Munday, who specialises in the investigation of fires and explosions, concluded that the origin of the fire was in the old dispatch area near the pallets of cardboard.
Having reviewed Fire and Rescue NSW’s records, Mr Munday noted that, when the firefighters arrived, the fire remained confined to the cardboard. If the brigade could have applied water or foam at that time, it is likely that the fire would have been contained, suppressed and extinguished. The problem was that the presence of stored ethanol in the old dispatch area affected the risk assessment of the situation. It was unlikely that any firefighters would have been committed into the area, once the storage of plastic drums containing ethanol was confirmed. For this reason, it was not possible to extinguish the burning cardboard before the developing fire spread to the ethanol.
Fire and Rescue NSW’s report noted that factors contributing to unusual fire behaviour were “hazardous contents”. The fire crew turned their hoses “onto exploding ethanol drums to attempt to slow a running ethanol fire in the drains”. An attempt to cut off the fire heading towards the factory “ultimately proved unsuccessful and the building was lost.”
Absent the ethanol, and with normal firefighting tactics applied, Mr Munday was of the opinion that it was very likely that the fire would not have spread from the old dispatch area into the factory. Ignition of the stored ethanol in the old dispatch area produced a rapid, intense high-level fire which spread into the main building, causing running liquid fires in the drainage system and led directly to the fire development within the premises. Storage of ethanol and ethanol-based products within the premises was the major contributor to the overall fuel loading and the spread and intensity of the fire beyond the old dispatch area. It prevented any significant internal fire suppression attacking tactics.
The insurer engaged Mr Sutarov to investigate the fire. On 14 July 2020, he inspected the Moorebank site with Mr Iordanou. Mr Sutarov took photographs over several days. He noted three storage containers in the dangerous goods area, with no evidence of fire damage. One storage container included eight empty IBCs labelled “ethanol”. The other storage containers were labelled “corrosive class 8” and “flammable liquid class 3” respectively and stored different types of dangerous goods. Empty ethanol drums and IBCs were also photographed on the diagonally opposite side of the site, unimpacted by the fire. Mr Sutarov counted 23 pallets containing 92 empty blue plastic drums, with the labels on the drums indicating that each drum had contained 160 kg (or 200 L) of ethanol.
As to how much ethanol was on the Moorebank site at the time of the fire, Sphere’s stock records indicate that there was 25,266 kg (that is, 31,270 L or 31 IBCs) on 6 July 2020. As to how much of that ethanol was in the old dispatch area, as opposed to the dangerous goods area, it looks like it was all in the old dispatch area. Mr Sutarov found eight empty IBCs labelled “ethanol” in the dangerous goods area. Mr Urbina said there was also about 100 pallets of cardboard in the old dispatch area, as there was nowhere to store this material inside.
It is not clear how much ethanol could have been stored in the dangerous goods area. What is known is that Mr Mufaddal had asked for a “split deliver” of 35,000 L from Wilmar BioEthanol, presumably as he apprehended that the dangerous goods area would not be able to store this amount of ethanol all at once. According to the supplier’s later email, Sphere did not place the order for the 35,000 L as they did not know “how they were going to manage the ethanol onsite.” What is also known is that, according to Mr Urbina, the ten IBCs delivered by Redox on 24 April 2020 were stored in steel cages within the bunded area.
It does appear from Mr Sutarov’s inspection that ethanol was stored in one of the three storage containers in the dangerous goods area. As such, the insureds submitted that the capacity of the dangerous goods area was three times the amount of ethanol delivered by Redox on 24 April 2020, that is, some 30,000 L. But Sphere used the other two storage containers for other dangerous goods used by its manufacturing processes, as observed by Mr Sutarov and, indeed, by Mr Iordanou in December 2015: see [54]. It may well be that, if the dangerous goods area had been re-arranged, then more ethanol could have been safely stored there, but I cannot speculate on that prospect. On the limited available evidence, I conclude that the dangerous goods area could store 10,000 L of ethanol in addition to its usual supply for manufacturing processes.
There is no dispute that a contract of insurance came into existence on 20 March 2020. The terms of that policy were LMIG ISR Mark IV Modified (V10-130925) AB wording as amended by ISR Schedule Reference Number BAW001-229-869. In dispute is whether this policy was cancelled and a new contract of insurance formed a week or two later. The significance of this issue is that the duty of disclosure, if any, continued until the contract was entered into: s 21(1), Insurance Contracts Act. As Sphere’s plans to make hand sanitiser evolved hour-by-hour, the date on which the contract of insurance was formed may be highly significant to whether any duty to disclose was observed.
The insureds submitted that, when they appointed the NSW broker, the WA broker had no actual or ostensible authority to represent the insureds. The WA broker’s request to Allianz to cancel the ISR policy was not a request for or on behalf of the insureds. The cancellation had no legal effect. The suggestion that the policy was cancelled relied on an email from the WA broker, who Allianz knew had no authority. Nor did the insurer take any steps consistent with cancellation.
Allianz accepted that, at 7.22 pm on 20 March 2020, the WA broker confirmed its client’s instructions to bind cover, such that Allianz and Sphere entered into an ISR contract of insurance on terms that had been issued by Allianz at 5.34pm that day. But the attempt to appoint a new broker had the consequence that this policy was never issued. The change of broker occurred at a time when cover had been extended, but the contract had not yet been formally closed, that is, premium invoices had not been issued or paid. The emails between the WA brokers and Aunew indicated that, prior to cancellation, Aunew knew that its agent, the WA broker, would cancel the cover on confirmation that it had been replaced as broker. Aunew authorised the WA broker, as its final act as its agent, to cancel the policy.
Allianz accepted that the NSW broker did request Allianz to transfer the policy, but submitted that it had already been cancelled. The change of brokers prior to closing the policy meant that, while it was clear that Aunew wished to be covered, the broking of the policy and its terms remained outstanding. The insurer’s solution was to revise the terms to be offered and send them to the NSW broker so that it could close with full authority. Cover was held while this process was underway. Contractually, this had to be under the old terms as no new terms had been offered or agreed. This is probably best characterised as formal cancellation being delayed.
As the learned authors of D Kelly & M Ball, Principles of Insurance Law (2024, LexisNexis, looseleaf) note, “The right to cancel a contract of insurance is derived from the contract itself. … A right to cancel a contract of insurance is not exercised in any event unless notice of the cancellation is given to the other party”: at [7.0080], citing Allianz Australia Insurance Ltd v Haddad [2015] NSWCA 186 at [26] (Beazley P, Meagher and Ward JJA). Here, the relevant party to be notified was the insurer.
The contract of insurance made on 20 March 2020 included the following condition:
“5. Cancellation
(a) This Policy may be cancelled at any time at the request of the Insured, in which case the Insurer(s) will retain the customary short-period rate for the time this Policy has been in force….”
The cancellation clause was the same as that considered in Deaves v CML Fire & General Insurance Co Ltd (1979) 143 CLR 24; [1979] HCA 12. Jacobs J considered that the right to terminate “depended on the request of the relevant insured. It did not require an acceptance of that request by [the insurer]”: at 71; likewise at 41 (Gibbs ACJ), 77 (Murphy J). In Federation Insurance Ltd v Wasson (1987) 163 CLR 303; [1987] HCA 34, Mason CJ, Wilson, Dawson and Toohey JJ analysed Deaves as supporting the view that “a request by an insured to the insurer to terminate the insurance operates as an automatic termination of the policy”: at 309.
Here, the instruction to cancel the policy was given by the insured’s broker to the insurer. The question is whether the WA broker had authority to do so. The ordinary scope of a broker’s authority is to effect insurance, but it is not “part of the ordinary duty or power of a broker to cancel agreements once validly and completely entered into”: Xenos v Wickham (1867) LR 2 HL 296 at 321 (Lord Cranworth); followed in Pacific & General Insurance Co Ltd v Hazell [1997] LRLR 65 at 76 (Moore-Bick J). As Gobbo J explained in Re Palmdale Insurance Ltd *(*in liq) [1982] VR 921 at 930:
“The particular course of dealing between particular brokers and their clients may, however, sustain an actual or an implied authority to cancel. This is a matter for enquiry in each case …”
In fact, the insureds did not wish to cancel the ISR policy for the Moorebank site. The insureds wanted to transfer the policy to the NSW broker. Whether Mr Yin and Mr Zeng informed the WA broker of their intention to transfer the policy is not known. But the WA broker must have appreciated that possibility, where its own letter of appointment envisaged that policies may be transferred on a change of broker: see [76].
What is also known is that the WA broker was displeased, no doubt because they had lost some $30,000 in commissions: see [133]. As the managing director of Austral Risk Services later put it, the WA broker was of the view that if the client was “going to seek terms elsewhere after the work they had done then it was best they go elsewhere.” Perhaps for this reason, the WA broker appears to have been keen to cancel the policy, rather than have the insureds benefit from the broker’s unpaid work in arranging it.
But when the emails, telephone calls and WeChat messages passing in and between Melbourne, Sydney and Perth are put in the correct sequence, it is clear that the WA broker instructed Allianz to “please cancel the policy” before the broker had obtained instructions from Aunew to do so: see [147]. The WA broker then pressed Mr Yin for instructions to cancel. Mr Zeng obtained confirmation from the NSW broker that changing brokers would not have the result that the policy was cancelled: see [152]. Mr Zeng then simply confirmed that Aunew had “decided to go with another broker”, that is, he gave no clear instruction to cancel the policy: see [151]–[152]. The WA broker’s prompt confirmation, “Confirm cancellation”, simply repeated instructions already given to Allianz but without authority. As such, the contract of insurance made on 20 March 2020 remained on foot.
Whilst Allianz did not have the benefit of a complete set of contemporaneous communications at the time, the insurer does not appear to have regarded the WA broker has having authority to cancel the policy either. Rather, over the course of the day, Allianz satisfied itself that the NSW broker was validly appointed. Allianz sought an explanation from the managing director of Austral Risk Services to explain the conduct of its authorised representative. Whilst it was not necessary for the insurer to confirm cancellation in order for it to have effect, if the instruction to cancel was valid, the fact that Allianz did not take any steps consistent with cancellation indicates that it did not regard the policy as having been cancelled at the time.
While the insureds contended that the contract for insurance was made on 20 March 2020, they sought a declaration that Allianz was liable to indemnify them under the policy schedule and policy wording later issued by Allianz’s NSW branch. For its part, the insurer contended that Sphere and Alliance entered into the policy on 2 April 2020, when Mr Pan confirmed that policy wording.
That is, it was common ground that the policy wording was that issued by Mr Pan, but the contractual route by which the parties arrived at that result was different. The significance of this debate is twofold. First, did the duty of disclosure continue beyond 20 March 2020 and, if so, to what date and to what extent? Second, when one considers what the insurer would have done in the counter factual, would underwriters have been considering the matter from the point of view of deciding whether to issue the policy at all, or through the ‘alteration of risk’ provisions?
The insureds contended, between 24 and 27 March 2020, the NSW broker and Allianz corresponded as to the administrative processes associated with transferring the policy from being linked in Allianz’s system to the WA broker, to being linked to the NSW broker. Any changes to the policy schedule and wording after 20 March 2020 were initiated by Allianz and referable to the change of broker, rather than any request by the insured. The differences in policy wording were said to be minor and did not amount to a ‘variation’ for the purposes of s 11(9)(b) of the Insurance Contracts Act. The premium and limit of liability were unchanged. The fundamentals remained the same. The changes in wording did not satisfy s 11(10A)(a)(i) or (ii) of the Insurance Contracts Act.
Allianz submitted that there were significant differences between the 20 March 2020 policy quotation and that issued by Mr Pan on 27 March 2020, including a change in the business description and the named insured. The policy wordings were both Mark IV ISR wordings but with materially different clauses. Relevantly, Endorsement UNDISYB4 was not in the 20 March 2020 policy. Cover was formally bound and closed on 2 April 2020.
Subject to subsection (10), a reference in this Act to the entering into of a contract of insurance includes a reference to:
…
(b) … the making of an agreement by the parties to the contract to renew, extend or vary the contract; or …
I agree that the insureds did not expressly ask to change the policy wording. The policy wording was changed because the insureds changed their broker, and that broker used a different policy wording. As such, by changing their broker, the insureds impliedly requested the change in wording and the insurer obliged. It does not matter. The question is whether the contract of insurance was varied or not, within the meaning of the Insurance Contracts Act.
I also agree that the variation in this case does not fall within the description in s 11(10A)(a)(i) or (ii). Subsection 11(10) relevantly provides:
Notwithstanding subsection (9):
…
(b) section 22 [insurer’s obligation to inform the insured of their duty of disclosure] and 40 [insurer’s obligation to inform the insured over various matters in respect of ‘claims made’ policies] do not require an insurer to give information to the insured at or before a variation of the contract of insurance unless subsection (10A) applies to the variation; …
This subsection applies to a variation of a contract of insurance if:
(a) the variation:
(i) is involved in a renewal, extension or reinstatement of the contract; or
(ii) will provide a kind of insurance cover that was not provided by the contract immediately before the variation; …
The subsection is directed to the scope of the insurer’s duty to notify the insured of various matters, and not the situation at hand: see P Mann, Mann’s Annotated Insurance Contracts Act (9th ed, 2024, Lawbook Co) at [11.130]. As such, the fact that the variation does not fall within s 11(10A)(a)(i) or (ii) does not matter either.
Returning to s 11(9), the purpose of the subsection is to make clear that obligations imposed “before the contract is entered into” apply where they renew, extend, vary or reinstate an existing contract and thereby make a new contract: Zurich Australian Insurance Ltd v Metals and Minerals Insurance Pte Ltd (2009) 240 CLR 391; [2009] HCA 50 at [18] (French CJ, Gummow and Crennan JJ). This reflects the position at common law.
An insured is not obliged to disclose adverse facts discovered after the insurer has accepted a risk but before the issue of the policy. As Blackburn J explained in Cory v Patton (1872) LR 7 QB 304, such disclosure would make the insurer “aware that his bargain was a bad one, information which ought to have no effect on him, but would expose him to a temptation to break his contract … [The insured] is not bound to lead his neighbour into temptation”: at 309. But the position is different if the policy is varied between acceptance of risk and policy issue. In Lishman v Northern Maritime Insurance Co (1875) LR 10 CP 179, Blackburn J concluded at 182:
“… if the alteration were such as to make the contract more burdensome to the underwriters, and a fact known at that time to the assured were concealed which was material to the alteration, I should say the policy would be vitiated. But if the fact were quite immaterial to the alteration… there would be no obligation to disclose it.”
“…If the new contract merely varies the original contract, the duty of disclosure applies only in respect of matters material to the variation… If, however, the variation has the effect of creating a new contract to replace the original contract, the duty applies in respect of matters that are material to the whole contract, not just to those matters that are material to the variation.”
Here, there was an agreement by the parties to vary the contract of insurance. The insureds had a duty to disclose matters to the insurer after 20 March 2020 until the contract was varied “with respect to all matters material to the alteration of the terms” (Lishman at 181 (Bramwell B)) or facts “material to the additional risk being accepted by the variation” (Manifest at [54] (Lord Hophouse) (Emphasis in original)).
As to the nature and extent of the variations in this case, the insureds submitted that the differences were minor. But there is an inconsistency in that submission. On the one hand, the insureds maintain that the contract of insurance was formed on 20 March 2020 and the duty of disclosure ceased at that point, as the swap of policy wording made no material change. On the other hand, the insureds embrace the later policy wording as it contains an endorsement that materially improves their position. Endorsement UNDISYB4 is only in the new policy wording. The insureds rely on this endorsement as the “complete answer” to the non-disclosure case. Allianz is said to have thereby contractually waived any entitlement to relief under s 28(3) of the Insurance Contracts Act. I do not think the insureds can have it both ways.
That is, if nothing else, Endorsement UNDISYB4 is a material change. If Sphere was only obliged to give disclosure in respect of that variation – which limits the insurer’s right to avoid the contract if the insured fails to comply with the duty of disclosure – then Sphere was obliged to inform the insurer of matters which may tell upon whether the insurer was giving up little or a very great deal. What facts were “material to the additional risk being accepted by the variation”: Manifest at [54]. As such, Sphere’s duty of disclosure would effectively continue until that variation was entered into.
As to the differences between the contract of insurance formed on 20 March 2020 and the policy schedule and wording later issued, the parties have carefully compared the documents. The insureds likely had the documents at the time and could have undertaken this exercise if they wished: see [125]. There is no suggestion in the contemporaneous records that they did so. Nor, as a practical matter, would one expect them to compare the (by my count) 119 pages of material, line by line, to identify differences between the two wordings, and then consider whether those differences were immaterial or material.
On my passing review:
The first policy document issued by Allianz’s WA branch is a “quotation” whilst the later document issued by Allianz’s NSW branch is a “policy schedule”. The “Important information” in the opening paragraphs of each document is different.
Whilst the insurer and period of insurance is the same, the broker is different, the policy reference number is different and the policy document is different. The premium is the same.
The insured is different, being Sphere in the later document and five entities in the earlier document. The definition of Business is different, with additional wording added to the later document.
The declared values and limit of liability are the same but the sub-limits are different. Eight heads of material damage which are “not insured” under the earlier document are insured under the later document, with sub-limits up to $250,000. A ninth item with a sub-limit of $25,000 under the earlier document has a sub-limit of $100,000 under the later document. The same can be said for sub-limits on items related to consequential loss of profits. Whilst declarations of acquired property are not insured under the earlier policy, they have a sub-limit of $2 million under the later policy. The deductibles are different.
There are multiple differences in the endorsements. According to the tables prepared by the parties, an endorsement appears in one policy wording, but not the other, on 57 occasions.
I have not found a case which considered the situation where the whole policy wording was replaced after the contract of insurance was formed. But I think the position is akin to Seven Cable Television Pty Ltd v Telstra Corporation Ltd [2000] FCA 350, where the nature and extent of the variations to an agreement were so extensive as to make it clear that a new independent contract was intended; the later agreement was so different that it replaced the earlier arrangement: at [134] (Tamberlin J).
Here, the later policy schedule and wording did not even refer to the earlier documents. It was as if they had never existed. I think the insurer’s summary of the position is accurate: “While the premiums, limits and sub-limits of cover were relevantly the same, each wording offered distinctly different cover … the two policies were distinctively separate.” The insurer replaced the earlier agreement but for the same price. I think it follows that, as the variation has the effect of replacing the original contract, the duty of disclosure applies in respect of matters that are material to the whole contract: Kelly & Ball, Principles of Insurance Law at [2.0080].
As to when the agreement to vary the contract of insurance was entered into, the contract of variation must itself satisfy the rules of contract formation: NC Seddon and RA Bigwood, Cheshire & Fifoot Law of Contract (11th Australian ed, 2017, LexisNexis Butterworths) at 212 [4.32]. When is there a clear indication by one person of a willingness to be bound on certain terms, met with an unqualified assent to that offer: JW Carter, Contract Law in Australia (8th ed, 2023, J W Carter Publishing) at 44 [3-02]?
As I read the email exchange between Allianz’s Mr Udayakumar and the NSW broker on 27 March 2020, Allianz provided the new policy schedule and wording and the broker acknowledged receipt. Allianz had certainly made an offer but the broker’s reply was not an acceptance.
The placing slip and closing issued by the NSW broker on 31 March 2020 is a likely contender for acceptance, save that the documents referred to the wrong policy number, being the earlier policy obtained by the WA broker. But Mr Pan’s action on 1 April 2020, sending the policy schedule through to the NSW broker for their records, is consistent with the closing and placing slip amounting to acceptance. The NSW broker sought clarification that the Steadfast wordings applied, as those wordings were not attached to Mr Pan’s email. Mr Pan confirmed the same on 2 April 2020 but, in truth, was simply re-stating what had earlier been advised when Allianz made the offer on 27 March 2020.
In sum, notwithstanding the (obvious) error in the closing and placing slip, I consider that Allianz’s offer was accepted on 31 March 2020 and the contract of insurance was varied on that date. The duty of disclosure continued to that date, subject to whether the insurer waived the insureds’ obligations in that regard by operation of Endorsement UNDISYB4 on Condition 1 of the policy or s 21(2)(d) of the Insurance Contracts Act.
“1. Misrepresentation and Non-Disclosure
If the Insured:
(a) failed to disclose any matter which the Insured was under a duty of disclosure to the Insurer(s); or
(b) made a misrepresentation to the Insurer(s) before this Policy was entered into
and if the Insurer(s) would not have entered into this Policy for the same premium and on the same terms and Conditions expressed in this Policy but for the failure to disclose or the misrepresentation, then:
(i) the liability of the Insurer(s) in respect of any claim will be reduced to an amount to place the Insurer(s) in the same position in which the Insurer(s) would have been placed if such non-disclosure had not occurred or such misrepresentation had not been made; or
(ii) if the non-disclosure or misrepresentation was fraudulent, the Insurer(s) may avoid this Policy.
[UNDISYB4] Misdescription, Non-Disclosure and Alteration
Condition 1 of the policy is extended to include the following paragraph:
Notwithstanding the provisions of Conditions 1 and 2, the Insured shall not be prejudiced by any unintended and/or inadvertent error, omission or misdescription of the risk, interest or property insured under the policy, failure to advise the Insurer(s) of any change of risk, interest or property insured or failure to comply with any statutory requirement, provided that the Insured's officer responsible for insurance shall, upon becoming aware of any such unintended and/or inadvertent act, error or omission, inform the Insurer(s) as soon as reasonably practicable and that the Insured shall, upon request, pay any reasonable extra premium to the Insurer(s) from the date of the increase in risk.”
(Amendments effected by endorsement underlined.)
The parties disagreed as to the proper construction of the condition and whether it applied. The insurer contended that Endorsement UNDISYB4 was not seeking to negative the operation of Condition 1. The endorsement was designed, by the use of the words “unintended and/or inadvertent”, to pick up slips and errors. Material non-disclosure did not fall within this rubric.
The insureds submitted that, by operation of Condition 1 as endorsed by Endorsement UNDISYB4, Allianz contracted out of relief otherwise generally available under Condition 1 and for equivalent relief under s 28(3) of the Insurance Contracts Act for unintended and/or inadvertent non-disclosure, and replaced it with an entitlement for a reasonable adjustment of premium. Condition 1(a) was directed to the duty under s 21(1) of the Insurance Contracts Act. Part IV Div 3 of the Insurance Contracts Act is a statutory code: Advance *(*NSW) Insurance Agencies Pty Ltd v Matthews (1989) 166 CLR 606; [1989] HCA 22 at 615. The duty described in s 21 is directed at a “matter”, being “a matter relevant to the decision of the insurer whether to accept the risk and, if so, on what terms.” The “risk” is a reference to the particular insurance hazard: Permanent Trustee Australia Ltd v FAI General Insurance Co**mpany Ltd *(*in liq) (2003) 214 CLR 514; [2003] HCA 25 at [32]. The endorsement removed general rights through the ‘shall not be prejudiced’ language: Council of the City of Wollongong v Vero Insurance Limited [2009] NSWSC 475 at [44]. Any omission to disclose a decision to make hand sanitiser fell within this description, being a failure to describe the “risk”. A failure to disclose that was not fraudulent would fit within the endorsement.
Condition 1 closely follows s 28 of the Insurance Contracts Act, which sets out the consequences which follow from fraudulent and non-fraudulent misrepresentation or nondisclosure before entry into a contract of insurance. Endorsement UNDISYB4 extends Condition 1, albeit referring to both Conditions 1 and 2. The endorsement sets up a mechanism available for non-fraudulent non-disclosures or misrepresentations only. And of these, it is only non-disclosures or misrepresentations where there has been an “unintended and/or inadvertent error” that the insured may avail themselves of the mechanism.
As McDougall J concluded, when considering a condition and endorsement in the same terms in Council of the City of Wollongong v Vero Insurance at [44]-[45]:
“44 … In terms, the extending paragraph, so far as it deals with condition 1, operates to protect the [insured], and to qualify [the insurer’s] rights, in the circumstances to which it applies. Those circumstances are to be understood by reference back to condition 1. They are non-disclosure and misrepresentation — the subject of subparas [(a) and (b)] respectively in condition 1. Where there are such matters, and where they are unintended or inadvertent, [the insurer] may not exercise the rights given to it by condition 1, provided that the [insured] makes disclosure of the relevant matter as soon as it becomes aware of it.
45 It is implicit in what I have said, but I should make it explicit, that I regard the words “unintended and/or inadvertent” as qualifying each of the matters that follow them, including misdescription of the risk and incorrect declaration of value. The parties intended to protect the [insured] against mistakes, not against the consequences of deliberate (even if “wrong”) decisions.”
I agree. Not every non-disclosure or misrepresentation will meet the description of “unintended and/or inadvertent”. As McDougall J put it, the provision protects the insured against “mistakes, not against the consequences of deliberate (even if “wrong”) decisions”. That is, non-disclosure may not be fraudulent but it may not be a mistake either.
Where there is an “unintended and/or inadvertent act, error or omission”, then the mechanism created by Endorsement UNDISYB4 is that, upon “the Insured’s officer responsible for insurance” becoming aware of this, the officer is to inform the insurer as soon as reasonably practicable and then pay any extra premium requested by the insurer for the increase in risk. No doubt there will be room for debate between the insured and their insurer as to whether they are entitled to use this mechanism in any given case. But Endorsement UNDISYB4 does not have the effect that Allianz contracted out of the duty of disclosure in s 21 of the Insurance Contracts Act at large.
As to whether Condition 1 applied in this case, the insurer’s primary contention was that Endorsement UNDISYB4 did not apply to Sphere’s non-disclosure of its decision to make hand sanitiser, because the failure to disclose that decision was not an error, omission or misdescription of the risk or any other failure within the meaning of the endorsement. As the endorsement operated as an exception to Condition 1, the onus of proof to establish that the insureds fell within the exception to an exclusion rested on them. Where Mr Zeng was the officer responsible for insurance within the meaning of Endorsement UNDISYB4, and he did not give evidence, Sphere had not proved that the error, omission or misdescription of the risk was “unintended and/or inadvertent”.
The insureds agreed that Mr Zeng was the officer responsible for insurance within the meaning of this endorsement but argued that there was no issue as to Mr Zeng’s state of mind given the insurer’s pleading of alternative arguments as to why the endorsement did not apply.
If the insurer did not establish its primary contention, then it pleaded, in the alternative, that (relevantly) Mr Zeng was not aware of any error, omission or misdescription of the risk or any other failure within the meaning of that endorsement. The insureds admitted this alternative contention.
But this does not establish the insureds’ entitlement to rely on Endorsement UNDISYB4. The insureds must prove that the non-disclosure was “unintended and/or inadvertent”. That is not proved by the insureds admitting that, if the non-disclosure was “unintended and/or inadvertent”, then Mr Zeng was not aware of it.
The insureds could have established that the non-disclosure was “unintended and/or inadvertent” by reference to contemporaneous documents, but there were none. The insureds could have provided this by calling a witness. Mr Zeng and Mr Yin both made affidavits but did not give evidence. Where the insureds have not established that the non-disclosure was “unintended and/or inadvertent”, then Condition 1 as amended by Endorsement UNDISYB4 does not apply.
It is convenient to consider whether Condition 2 of the policy document, and its endorsements, applied such that the insurer was liable for loss caused by the alteration in risk after inception of the policy. The parties disagreed as to the proper construction of Condition 2, as endorsed, and its application.
Condition 2 of the policy document, as amended by Endorsements ALTERXS4 and ALTERVS4, provided:
**“**2. Alteration
[ALTERXS4] Subject to Section 54 of the Insurance Contracts Act 1984, the Insurer(s) shall not be liable for loss, destruction of or damage to any property insured hereunder caused or contributed to by any alteration after the commencement of this Policy:
(a) by removal of such property from the Premises other than as provided under the terms of Property Exclusion 1 [which limits liability for loss to property while in transit other than during the incidental movement of property within situations occupied by the Insured];
(b) in the trade or processes of manufacture carried on at the Premises or whereby the nature of the occupation or other circumstances affecting the Premises and/or the Insured’s property therein contained shall be changed in such a way as to increase the risk of loss, destruction or damage;
(c) whereby any premises containing any property insured hereunder shall become unoccupied, and so remain for a period of more than thirty days; or
(d) whereby the Insured’s interest ceases except by will or the operation of law.
Provided that any such alteration, upon coming to the knowledge of the Insured’s officer responsible for insurance, shall be immediately notified to the Insurer(s) and, if agreed to by the Insurer(s) in writing, an appropriate additional premium paid if required.
[ALTERVS4] Condition 2 is extended to include the following additional provision:
Provided further that paragraphs (a) and (b) of this Condition 2 shall not apply if such alteration(s) are neither known to nor made by an officer of the Insured who is responsible for Insurance.”
(Amendments effected by endorsements underlined.)
As to the proper construction of the condition, Allianz contended that the text and commercial purpose of the second proviso to Condition 2, added by ALTERVS4, supported a conclusion that the use of the words “an officer of the Insured who is responsible for insurance”, as distinct from “the Insured’s officer responsible for insurance”, evinced an intention that the class of officer was wider than the singular officer identified in the first proviso. As to commercial purpose, the second proviso, if satisfied, had the result that if the relevant alteration was not known by the officer, then an important right of Allianz under Condition 2 was negatived. It was commercially rational for the relevant knowledge in those circumstances to be expanded beyond the single officer responsible for insurance referred to in the first proviso. Otherwise, an insured could inoculate itself by the one person in the first proviso just not knowing about a massive alteration in risk.
The insureds noted that alterations in risk were rare at common law: Kausar v Eagle Star Insurance Co Ltd [2000] Lloyd’s Rep IR 154 at 156-7 (Saville LJ). The parties had addressed this contractually in the second proviso in Endorsement ALTERVS4. There were minor linguistic variations in the policy and the schedule as to the way in which the ‘insurance officer’ was described. These terms were used interchangeably. The use of “the” and “an” did not detract from identification of the person nominated by the insured to notify and inform the insurer of matters. To proceed otherwise would create uncertainty, where the words should be given a business-like interpretation: McCann v Switzerland Insurance Australia Ltd (2000) 203 CLR 579; [2000] HCA 65 at [22] (Gleeson CJ).
The policy schedule and policy document contain no relevant definitions. Condition 2 refers to “the Insured's officer responsible for insurance” in the first proviso, as does Endorsement UNDISYB4 and Endorsement SPRAYPC4 “Sprinkler Installations”. Endorsement BREAKXB4 – Breach Of Conditions –refers to “the Insurance Officer of the Insured”. Endorsement ALTERVS4, which creates the second proviso, refers to “an officer of the Insured who is responsible for Insurance”. Presumably, the choice of language was intentional.
Putting Endorsement ALTERVS4 to one side for the moment, Condition 2 provides that Allianz is not liable for loss caused by an alteration in risk after commencement of the policy unless, on becoming aware of the alteration in risk, “the Insured’s officer responsible for insurance” takes certain steps. The first proviso creates a mechanism by which the parties can address any alteration in risk during the period of cover. If the mechanism is activated, then the insurer can either agree to bear the additional risk (with or without an additional premium) or decline to do so, in which case it will not be liable for loss caused by the alteration in risk.
Obviously enough, if the Insured’s officer responsible for insurance does not know about the alteration in risk, then they cannot avail themselves of this mechanism and the insurer will not be liable for loss caused by the alteration in risk. Condition 2 and the mechanism in the first proviso creates an incentive on the Insured’s officer responsible for insurance to stay abreast of alterations in risk.
What does the second proviso add to this contractual arrangement? And what is it about paras (a) and (b) of Condition 2 that warrants special treatment in Endorsement ALTERVS4, as opposed to paras (c) and (d)? Paragraphs (a) and (b) of Condition 2 describe actions of the Insured which immediately alter the risk: removing insured property from the Premises or changing the Insured’s trade or processes of manufacture. These acts might be thought more likely to immediately increase risk, either because removing property insured from the Premises might be thought to generally have that effect, or because para (b) expressly refers to changes in trade or manufacturing processes “in such a way as to increase the risk”. Paragraphs (c) and (d) of Condition 2 describe more gradual events which alter risk: premises containing insured property become unoccupied for more than 30 days or the Insured’s interest in the insured property comes to an end. Whilst premises becoming unoccupied for a prolonged period might be thought to increase risk, the fact that the Insured ceases to have an interest in the insured property might be thought likely to reduce risk.
And it is these differences between the actions taken by the Insured in paras (a) and (b) of Condition 2 and the events described in paras (c) and (d) which explains the need for the second proviso. The events described in paras (a) and (b) may bring about an immediate alteration in risk which may not come to the attention of the Insured’s officer responsible for insurance before something goes wrong. The events described in paras (c) and (d) are events which the Insured’s officer responsible for insurance has time to plan for, or be alive to, and to activate the mechanism in the first proviso.
Endorsement ALTERVS4 gives additional protection to the insured in circumstances where there is likely to be an immediate increase in risk as a result of the Insured’s actions. But that will only be the case if additional requirements are satisfied. The alteration in risk must be “neither known to nor made by an officer of the Insured who is responsible for Insurance.” If these requirements are satisfied, then the events in paras (a) and (b) are removed entirely from Condition 2. The Insured’s officer responsible for insurance does not need to activate the mechanism in the first proviso. The insurer will not have the opportunity to refuse to cover the altered risk, nor the opportunity to receive an additional premium for their troubles. The quid pro quo is, basically, that this change was not known to or brought about by someone who should have known better than to take this step without notifying the insurer of the alteration in risk.
It seems unlikely that, in an industrial setting, “the Insured’s officer responsible for insurance” referred to in the first proviso will be the same person making the decision to remove insured property from the Premises or to change the Insured’s trade or manufacturing processes. If they were the same person, then the second proviso confers a substantial benefit on the insured but with no corresponding burden. It would have been simpler to just delete paras (a) and (b) of Condition 2 and be done with it. Presumably the second proviso was intended to have some meaningful operation to balance the interests of the contracting parties.
Further, reading the second provision in the manner contended for by the insureds will undermine the incentive created by Condition 2, for the Insured’s officer responsible for insurance to keep abreast of changes in risk and to communicate with the Insurer in a timely manner. In the events described in paras (a) and (b), which describe events which, by their nature or express description, are likely to immediately increase the risk of loss, all that the Insured’s officer responsible for insurance need do to protect the Insured’s interests is to make sure that they do not know about it and take no part in it. That would defeat the purpose of the clause. As observed in Onley v Catlin Syndicate Ltd [2018] FCAFC 119, “It goes without saying that a construction that avoids capricious, unreasonable, inconvenient or unjust consequences, is to be preferred where the words of the agreement permit”: at [33] (Allsop CJ, Lee and Derrington JJ).
For these reasons, I conclude that the contracting parties intended that the description of the officer in the second provide be given an expansive reading. The officer was not necessarily the same person as “the Insured’s officer responsible for insurance” referred to in the first proviso.
As to the application of the condition, the insurer contended that Mr Zeng was the Insured’s officer responsible for insurance for the purposes of the first proviso in Condition 2. But the first proviso did not apply because Mr Zeng did not have subjective knowledge of the alteration in risk. The insurer submitted that Sphere bore the onus of proof to establish that the exceptions to Condition 2(b) were established. The first proviso only applied where the relevant alteration came to the knowledge of “the Insured’s officer responsible for insurance”. There was no evidence that the alteration came to Mr Zeng’s knowledge. Nor was there reason to draw an inference favourable to Sphere in the absence of calling Mr Zeng.
As for the second proviso, Allianz contended that Mr Singh and Mr Cai were both “an officer of the Insured who is responsible for Insurance” within the meaning of that proviso. But both gentlemen knew of the alteration in risk and thus the second proviso did not apply either. The insurer submitted that Mr Singh and later Mr Cai fitted the description of being an officer of the Insured responsible for insurance. Both Mr Singh and Mr Cai were aware of the alteration in the risk. The insurer pointed to communications concerning insurance which involved Mr Cai, both before and after the fire, from which an inference could be drawn that Mr Cai had responsibility for insurance given his position at Sphere. On 28 July 2020, Mr Yin advised the loss adjuster of his progress in arranging a demolition company and copied Mr Cai. On 23 September 2020, Mr Cai wrote to Allianz, complaining about the delay in confirming indemnity. Where Mr Cai did not give evidence, the Court would draw that inference with greater confidence. For that reason, the second proviso was not engaged.
The insureds contended that Mr Zeng was the officer responsible for insurance within the meaning of Condition 2 as a whole. They agreed that Mr Zeng did not have knowledge of the alteration in risk. They denied that Mr Singh and Mr Cai were officers of Sphere with responsibility for insurance within the meaning of the second proviso, and also denied that these gentlemen knew of an alteration in risk. The insureds submitted that Allianz bore the onus of proving that the alteration was known to the officer responsible for insurance: Kodak (Australasia) Pty Ltd v Retail Traders Mutual Indemnity Insurance Association (1942) 42 SR (NSW) 231 at 237 (Jordan CJ). That person was Mr Zeng. Due to Mr Zeng’s admitted lack of knowledge, Condition 2 did not apply by virtue of Endorsement ALTERVS4.
The mechanism in the first proviso was not activated in this case. The parties agree that Mr Zeng was the Insured’s officer responsible for insurance. Where the insurer pleaded as a positive fact that the first proviso did not apply “because Mr Zeng did not have subjective knowledge of the Alteration in Risk”, and the insureds admitted that assertion, then the insurer is bound by that admission. The insureds did not need to call Mr Zeng to prove that he did not know. But nor does it advance matters for the insureds; having not activated the mechanism in the first proviso, the insurer is not liable for any loss caused or contributed to by the alteration in risk unless the second proviso applies.
The applicability of the second proviso involves two questions. First, were Mr Singh or Mr Cai “an officer of the insured who was responsible for Insurance”? Second, did either Mr Singh or Mr Cai know about, or make, any alteration in the trade or processes of manufacture carried on at the Moorebank site in such a way as to increase the risk of loss, destruction or damage?
As to the first question, the insureds placed much weight on the arrangements reached under the DOCA, including the Interim Management Deed and the two Shared Services Agreements between Aunew, on the one hand, and GMP and Sphere respectively, on the other hand. That may well have been the arrangements that were reached within the Aunew corporate group. But none of these documents were provided to Allianz, either to Mr Keuneman in Perth or subsequently. The Shared Service Agreement between Aunew and Sphere did not then exist but was executed in 2021 and given retrospective effect. Nor, for that matter, was arranging insurance a Service mentioned in the Shared Services Agreement.
The insureds argued that Mr Singh was not an officer of the insured who was responsible for insurance, given the terms of the DOCA. This suggestion was not mentioned in the insureds’ extensive pleading or their 95 pages of closing written submissions. The argument was made orally and at length. The insurer submitted in reply that this should have been pleaded as then the insurer would have pleaded a good faith point if the insureds contended that an endorsement had no meaningful operation because of a want of authority. I accept that submission and will not delve into the interstices of the DOCA.
But in any event, the question here is a proper construction of the contract of insurance. In construing the policy, the internal arrangement of the Aunew group of companies are not surrounding circumstances known to both parties or receivable as an aid to construction: Codelfa Construction Pty Ltd v State Rail Authority (NSW) (1982) 149 CLR 337; [1982] HCA 24 at 352.
The Insured was Sphere, not Aunew (where Mr Zeng worked). As I understand the arrangements from the contemporaneous documents, Mr Singh was the most senior employee at the Moorebank site and in charge of operations. Mr Cai became his deputy and, in June 2020, Mr Singh’s successor. As managers, Mr Singh and Mr Cai were both asked to direct insurance inquiries to Mr Zeng: see [72]. Implicit in that instruction is that the managers’ role included identifying insurance issues as they arose on site.
Mr Singh did liaise with Mr Zeng in relation to particular insurance needed for the Moorebank site, even before the instruction to managers was issued: see [65]. Mr Cai did raise an issue as to whether Sphere’s insurance responded to a particular problem then being experienced, and asked how he could best prepare to make any claim: see [110]. I have put post-fire communications with Mr Cai on insurance matters to one side.
As the most senior employees on the Moorebank site, I consider that both Mr Singh and Mr Cai were “an officer of the Insured who is responsible for Insurance” within the meaning of the second proviso. Their role necessarily required them to have an eye to the implications of what was going on at the Moorebank site for the company’s insurance.
The final question is whether either Mr Singh or Mr Cai knew about, or made, any alteration in the trade or processes of manufacture carried on at the Moorebank site in such a way as to increase the risk of loss, destruction or damage. It is plain from the contemporaneous documents that both gentlemen were well aware of the changes that were going on and made the decisions to implement those changes. Specifically, when Mr Cai suggested to Mr Singh and others on 23 March 2020 that Sphere should import alcohol from China, GMP’s R&D Manager – ANZ, Mr Chitneni replied to both gentlemen, “Take into consideration this to be a dangerous good (highly flammable).” Both gentlemen had been copied on an email from Ms Dong on 30 March 2020, advising that the liquid manufacturing section had to be modified “to explosion proof level” to manufacture ethanol-based hand sanitiser. On 3 April 2020, Mr Singh authorised Mr Cai to place a purchase order for 60,000 L of ethanol to be imported from China.
On 22 April 2020, both gentlemen received an email from Mr Urbina, raising concerns about the bulk delivery of ethanol, including that the dangerous goods area was inadequate, there were no proper control measures in the case of spillage and personnel were untrained. On 5 May 2020, Mr Cai and Mr Singh’s assistant received an email from the customs officer, advising that the ethanol arriving from China was classed as Dangerous Goods Class 3. On 13 May 2020, Mr Singh had a meeting with Sphere’s Head of Quality as to how the 80 IBCs of ethanol could be received, reportedly concluding that the risk was “bare minimum”. In June 2020, Mr Cai took over from Mr Singh, being at a time when the manufacture of hand sanitiser was underway.
I conclude that the alterations in risk brought about by the events described in Condition 2(b) were “known to [and] made by an officer of the Insured who is responsible for Insurance”. The requirements of the second proviso are not satisfied. Allianz is not liable for loss caused or contributed to by any alteration after the commencement of the policy. The insureds accepted that the storage of bulk ethanol on the site was an alteration of risk that caused or contributed to the loss.
Returning to the duty of disclosure, the insureds contended that Allianz waived any requirement for disclosure: s 21(2)(d), Insurance Contracts Act. The insureds relied on the years of coverage conferred by the insurer, together with the insurer’s practices. Allianz had provided ISR cover to Sphere since 2012. Allianz’s practice in underwriting these policies was not to use proposal forms but to gather information for the purpose of assessing risk itself. Allianz conducted its own physical inspections and surveys of the site, issued RIRs, communicated with Sphere as to any steps taken in response to the RIRs, posed specific questions and otherwise used existing information which it held about the insureds. Changes or alterations to the insured risk on account of changes or alterations in Sphere’s business during the policy period were said to be habitually addressed by the parties’ use of an alteration of risk clause.
Further, the insureds contended that Allianz underwriters were told that the business of Sphere was “Principally products & health foods contracted manufacturer”. The insurer knew from its historical relationship with Sphere that the Moorebank premises stored hazardous chemicals for use in its manufacturing processes. Allianz determined what further information it needed from the WA broker for the purposes of assessing the risk and posed questions to the broker to obtain that information. The insurer decided to provide cover without a current physical survey and without imposing conditions. It sought no additional information as to the specifics of Sphere’s manufacturing business, including any information as to what products Sphere might manufacture during the term of the policy. Allianz did not request a product listing or ask about raw materials, manufacturing processes, contracts for manufacture or future plans. While Allianz knew that Sphere stored ethanol, it asked nothing about this. Allianz offered cover in circumstances where the last survey was in 2015 and everything since was a ‘desktop’ review.
The insureds submitted that the case law in this area generally proceeded on the basis that the relevant information flow was wholly from the insured to the insurer. But that was not this case. Here, the insurer knew enough to enquire but did not seek out the rest of the information: QBE Underwriting Ltd as managing agent for Lloyds Syndicate 386 v Southern Colliery Maintenance Pty Ltd (2018) 97 NSWLR 459; [2018] NSWCA 55 at [103]-[106] (Leeming JA, Macfarlan and Payne JJA agreeing); Asfar & Co v Blundell [1896] 1 QB 123 at 129-30 (Lord Esher MR), 131 (Lopes LJ), 133-4 (Kay LJ); Roumeli Food Stores *(*NSW) Pty Ltd v The New India Assurance Co Ltd [1972] 1 NSWLR 227 at 233-4 (Macfarlan J); QBE Insurance *(*International) Ltd v Jaggar [2007] 2 NZLR 336 at [35] (William Young P). Allianz knew that the information it had on the Moorebank premises was dated. There was potential for the premises to change in the meantime. Where the ARCA reports made clear that Sphere stored ethanol on site, the insurer was put on enquiry as to capacity of storage but did not enquire, waiving any right to the duty to disclose that further information. While Mr Keuneman asked whether the general descriptions of business activity in the quote slip remained accurate, he could have asked for product listings, contracts with clients and future intentions. Where he did not, it was said that Allianz waived any requirement to disclosure in these areas.
The insureds submitted that Allianz continued to waive any duty of disclosure which may have applied from 20 March 2020 until the new policy wording was in place. During this period, Allianz made it clear that it had completed its underwriting process and was bound. The insurer did not ask any underwriting question of the NSW broker nor request continuing disclosure to accommodate the transfer.
The insurer submitted that waiver only arises when the insurer is “put on enquiry about some particular matter [such that] it can be said that they have waived the obligation…”: Arterial Caravans Ltd v Yorkshire insurance Co Ltd [1973] 1 Lloyd’s Rep 169 at 180-1. The question is whether there has been a fair presentation of the risk by the insured and the insurer has communicated that further details are not required: WISE Underwriting Agency Ltd v Grupo Nacional Provincial SA [2004] EWCA Civ 962; Hitchens v Zurich Australia Ltd [2015] NSWSC 825 at [129]-[140] (White J); J&J Richards Super Pty Ltd v Nielsen [2024] FCA 1472 at [290] (Halley J). Where there was no proposal form that asked questions of insured, the principle was of narrow application and directed to whether the insureds provided a fair presentation of the risk. There was no fair presentation of the risk here, but a simple “Confirm no change in business activity”.
Section 21(2)(d) of the Insurance Contracts Act 1984 (Cth) provides that the insured’s duty of disclosure “does not require the disclosure of a matter … as to which compliance with the duty of disclosure is waived by the insurer.” “Waiver” in s 21(2)(d) takes its meaning from how that concept has been applied in insurance law: Hitchens v Zurich Australia at [134] (White J). The concept stems from marine insurance.
The seminal case is Carter v Boehm (1766) 3 Burr 1905, where the governor of Port Marlborough in Sumatra insured a fort against being taken by the French. The question was whether letters from the governor and to the East India Company – indicating that there was every chance that the French would take the fort – should have been disclosed. In illustrating the principle of waiver, Lord Mansfield said, “If an underwriter insures private ships of war … he needs not be told, the secret enterprizes they are destined upon; because he knows some expedition must be in view; and, from the nature of his contract, without being told, he waives the information”: at 1165. Waiver of disclosure in such circumstances is founded on notions of fairness. As Lord Mansfield further explained, “The question … must always be “whether there was, under all the circumstances at the time the policy was under-written, a fair representation; or a concealment … though not designed … changing the risque understood to be run”: at 1165.
Not much has changed, albeit the principle has been expressed in various ways. The duty to disclosure is satisfied if the insured “discloses sufficient to call the attention of the underwriters in such a manner that they can see that if they require further information they ought to ask for it”: Asfar & Co v Blundell at 129 (Lord Esher MR); cited with approval in QBE Underwriting v Southern Colliery at [103] (Leeming JA, Payne and Macfarlan JJA agreeing).
More recently, it has been said that whether there has been waiver by an insurer involves two questions. As Longmore LJ (Peter Gibson LJ agreeing) summarised the position in WISE Underwriting Agency v Grupo Nacional Provincial at [111]:
“So the question becomes: (a) was there a fair presentation of the risk? And (b) was the insurer in the course of that presentation … put on enquiry by the disclosure of facts which would raise in the mind of a reasonable insurer at least a suspicion that there were other circumstances which would or might vitiate the presentation?”
“The reasonably careful underwriter is neither a detective on the one hand nor lacking in common sense on the other hand. Mere possibilities will not put him on inquiry, and very little if anything can make up for non-disclosure of the unusual or special. Overriding all, however, is the notion of fairness, and that applies mutually to both parties, even if the presentation starts with the would-be assured.”
“… before an insurer can be held to have waived an insured's obligations of disclosure, the insured must have fairly disclosed the existence of the risk and the insurer has communicated, expressly or by silence, that further particulars or details of the risk are not required.”
A simple example of waiver of the duty of disclosure under s 21(2)(d) is ABN AMRO Bank NV v Bathurst Regional Council (2014) 224 FCR 1; [2014] FCAFC 65, where the insurer made clear to the broker that it did not require a proposal form to be completed but required only financial statements: at [1711] (Jacobson, Gilmour and Gordon JJ).
As the insureds’ submission conceded, their argument is not readily supported by the case law. And their argument was, in short, that the more an insurer investigates a risk for themselves, the less an insured has to disclose a matter pertaining to that risk unless squarely asked. That is, the duty of disclosure is waived by the insurer’s efforts. The submission does not sit well with the statutory language or the common law on which the statute is based. An insurer may not be prepared to take the insured’s word for it, when describing the state of affairs on an industrial site. An insurer may invest time and money in examining the site for themselves. But an insurer presumably undertakes these activities against the statutory backdrop that the insured has a duty of disclosure. If, by investing in risk surveys and the like, the insurer’s expenditure abrogates the insured’s duty, then no insurer would do it and ISR policies may be hard to come by.
Looking at whether the insurer did not require the disclosure of a matter under s 21(2)(d) of the Insurance Contracts Act when agreeing to provide cover on 20 March 2020, and when agreeing to do so again on different terms on 31 March 2020, it is true that Allianz had insured Sphere in the past. But that ISR policy had been cancelled.
When Allianz was asked to insure the risk again in March 2020, Allianz’s WA branch had never dealt with this risk and the WA broker was new to the risk too. The suggestion that the WA broker’s email to Allianz’s WA branch on 3 March 2020 – “All other files should be in your system. Please let me know if you need anything else” – was entirely in line with the way in which Allianz had historically insured Sphere, puts the matter too highly. There is no evidence that the WA broker had any particular insight into Allianz’s practices or procedures or was aware of the extent of historical information available to the underwriter. Further, Aunew was now seeking insurance on behalf of Sphere, and there is no suggestion that Aunew had any particular insights into what Allianz knew or had beyond Mr Iordanou’s RIRs.
What the insurer did know was that things had changed since it had last insured this risk. Specifically, Sphere had been in external administration and had been purchased by a third party. The business was now being run by new owners. Mr Keuneman’s questions to the WA broker clearly asked: what has changed? He was particularly interested in what had happened when the company was in external administration: whether the company had been insured during that period and what claims, if any, had been made. Further, Mr Keuneman asked “Please confirm there has been no change in business activity as per your slip.” It will be recalled that the WA broker’s slip had described activity at Moorebank as “Manufacture of health care and milk powder products.” On 18 March 2020, the WA broker confirmed that there had been nil claims during external administration and, further, “Confirm there is no change in business activity.” That is, Sphere was still making health care and milk powder products.
Turning to the first question posted in WISE Underwriting Agency v Grupo Nacional Provincial, was this a fair presentation of the risk? No. As at 18 March 2020, a fair presentation of the risk would, I think, have included advising that, in addition to manufacturing health care and milk powder products, the company’s new owners had decided to make hand sanitiser gel on the Moorebank site. The main ingredient in that product was ethanol. While the company had always used ethanol in its production processes, it now needed much more to make this new product. The company did not know how it was going to manage the storage of the larger quantities of ethanol on site, but the company was resolved to proceed with the new product.
Even if the answer to the first question is ‘yes’, what it is about the WA broker’s communication – “Confirm there is no change in business activity.” – that put the insurer on enquiry by raising “at least a suspicion that there other circumstances which would or might vitiate the presentation?”: WISE Underwriting Agency v Grupo Nacional Provincial at [111] (Longmore LJ). There was nothing. The abiding message was that, notwithstanding that it looked like a lot may have changed, in reality, it was the same risk. The new owners had been Sphere’s “landlord for all these years” such that the fact that the new owner was “now operating instead of [being the] property owner” was not as significant as it might otherwise have been thought.
Mr Keuneman obviously understood that it was ‘business as usual’, describing Sphere’s activities on 19 March 2020 as “Manufacture and Distribution of natural and nutritional pharmaceutical products including coating of tablets, extraction of liquids from vegetation, liquid herbal extracts …”. When Mr Pan later reviewed the underwriting to confirm that the risk was acceptable, he relied on Mr Keuneman’s enquiry and the broker’s confirmation that there had been no change in business activity.
I am not satisfied that the insurer waived the duty of disclosure under s 21(2)(d) of the Insurance Contracts Act as there was no fair presentation of the risk. Rather, in response to the insurer’s direct questions as to whether there had been any change, the insured represented that there had been no change in business operations. Nor was there anything in the presentation of the risk that would have put the insurer on enquiry that more questions should be asked. This brings as to whether the duty of disclosure was complied with.
The insurer contended that the failure to inform it of the decision to manufacture hand sanitiser was a material non-disclosure and breach of the policy: s 21(1)(b), Insurance Contracts Act; Condition 1. At some time before entry into the contract of insurance, Mr Cai, Mr Singh, procurement officer Mr Mufaddal and procurement manager Ms Halligan knew that Sphere had decided to manufacture hand sanitiser at the Moorebank premises and was intending to commence the manufacture within the proposed period of insurance. Sphere was aware of this decision via the knowledge of Mr Cai, Mr Singh, Mr Mufaddal and / or Ms Halligan. Sphere had a duty to disclose this before entry into the contract.
The insurer submitted that, where the risk being transferred to Allianz under the policy was for $26.8 million, a reasonable person in Sphere’s position at the date of entry into the contract of insurance would appreciate the materiality of a decision to start manufacturing hand sanitiser in the short term by proposing to bring large quantities of a highly flammable raw product onto the premises. Once made, the hand sanitiser was largely alcohol and would also be on the premises for some time. Under the policy, Sphere was insured not only for the ethanol as raw material but the hand sanitiser as product. This was without even considering the obvious concern that something that dangerous and flammable might set the whole place on fire. It was said to be a slightly unreal proposition that someone that knew that they were entering into this policy with this level of cover for the buildings, contents and stock would not have appreciated the materiality of that proposed activity.
The insurer further submitted that Allianz had a longstanding interest in fire protection of the Moorebank site, as demonstrated by its surveys and RIRs. Sphere would have known that the insurer had an intense interest in fire safety at the premises. It would have been obvious to a reasonable person in the position of the insured that they were planning to move into production of a highly flammable product. The description of Sphere’s business in the placing slip did not come close to fairly disclosing the nature of this activity.
The insureds accepted that, in late January 2020, Sphere was exploring the possibility of manufacturing hand sanitiser at the premises. But without a reliable, committed supplier of ethanol, this was nothing more than a concept. Concerted efforts to secure a locally available, committed supply of enough ethanol were largely unsuccessful. It was meaningless to suggest that Sphere had decided to make hand sanitiser in the absence of securing the primary and essential agreement. The insureds did not know that Sphere would be manufacturing hand sanitiser at any point during the period of insurance.
The insureds submitted that, for practical purposes, the relevant date for disclosure was the date on which Allianz was bound to provide cover for the relevant period of insurance, being 20 March 2020. The policy endorsements offered by Allianz to Sphere over the years included an alteration of risk clause by which the matter could be addressed as and when a supply of ethanol was found. After this date, Allianz had already accepted the risk. Allianz did not make any request of the insureds or the broker for continuing disclosure, or further information beyond confirmation that the NSW broker was authorised. A reasonable person in the circumstances of the insureds would not have understood that matters that first came to their knowledge after 20 March 2020 were matters that could affect Allianz’s decision to accept the risk, or the terms of that acceptance, where Allianz had already confirmed that the risk was accepted and had identified and issued terms.
The only thing which had changed was that Sphere had begun to make some enquiries overseas for a possible supply of ethanol, but no supplier had been found. On 3 April 2020, Sphere issued a purchase order to an overseas supplier. But significant uncertainties remained, including when and whether the ethanol would arrive. Sphere adopted a step-by-step approach; it did not contract with JBX until after it received confirmation that the ethanol had arrived in Australia. Questions of how and where that ethanol would be stored were not addressed until well into the period of insurance.
The insureds further contended that, as at 20 March 2020, they knew how Allianz gathered information for the purposes of underwriting, in particular, via Sphere’s responses to RIRs. Allianz had made some specific inquiries of the WA broker, which the broker answered. Allianz had asked no questions about any products manufactured, including current product listings or ingredients used, contracts past, future or proposed, past present or future manufacturing processes, raw materials or finished stored at the premises or raw or finished products that may have been held in storage at the premises during the term of cover. Where Allianz was said to have historically insured Sphere on the basis of an alteration of risk clause, which provided for Sphere to notify it in the event of changes occurring during the term of the policy, a reasonable person in the circumstances would not be expected to know that the decision to make hand sanitiser was relevant to the insurer’s decision whether to accept the risk and, if so, on what terms.
The insureds contended that, when the insurer posed questions, those questions were directed to past and present matters, but not to future matters. When the contract for insurance was formed, Sphere had not undertaken any business of manufacturing hand sanitiser, as it was yet to determine whether it could do so. Sphere had yet to identify any supplier of ethanol that would, or could, commit to supply in quantities sufficient for Sphere to further progress any dealing with the one client who was seeking to contract with Sphere for the manufacture of hand sanitiser. Nor did the insurer have any particular interest in fire safety. Rather, the insurer offered cover when it knew that the Moorebank premises did not have sprinkler protection, the hydrant water supply flow testing had not been completed and the insurer did not know whether the premises complied with fire and council regulations.
Further, Sphere had not taken any decision to acquire ethanol in quantities that, even if all orders were received at the Moorebank premises, would not be capable of being stored within the ordinary storage facilities at the premises for the storage of hazardous chemicals. The insured had not taken any decision concerning the future storage of quantities of ethanol at the premises or elsewhere, in the event that ethanol was sourced, acquired and delivered in volumes that were greater than that which could be accommodated in the designated storage areas at the premises. Nor had Sphere taken any decision as to the production and delivery schedules and associated storage requirements for hand sanitiser as a finished product.
(1) Subject to this Act, an insured has a duty to disclose to the insurer, before the relevant contract of insurance is entered into, every matter that is known to the insured, being a matter that:
(a) the insured knows to be a matter relevant to the decision of the insurer whether to accept the risk and, if so, on what terms; or
(b) a reasonable person in the circumstances could be expected to know to be a matter so relevant, having regard to factors including, but not limited to:
(i) the nature and extent of the insurance cover to be provided under the relevant contract of insurance; and
(ii) the class of persons who would ordinarily be expected to apply for insurance cover of that kind.
While s 21(1)(a) looks only to what the insured knows, subs (1)(b) looks to what a reasonable person could be expected to know, taking into account the circumstances affecting the actual insured but without taking into account their subjective state of mind: GIO General Ltd v Wallace [2001] NSWCA 299 at [23] (Heydon JA, Priestley and Hodgson JJA agreeing); CGU Insurance Ltd v Porthouse (2008) 235 CLR 103; [2008] HCA 30 at [52] (Gummow, Kirby, Heydon, Crennan and Kiefel JJ).
“Know” means considerably more than “believe” or “suspect” or even “strongly suspect”: Permanent Trustee v FAI at [30] (McHugh, Kirby and Callinan JJ). The insured must not only know a matter, but must know it to be “a matter relevant to the decision of the insurer whether to accept the risk and, if so, on what terms”: at [29]. As to the risk, the focus of attention is on the particular insurance hazard: at [32].
Whether a matter is known is a question of fact: Commercial Union Assurance Co of Australia Ltd v Beard (1999) 47 NSWLR 735; [1999] NSWCA 422 at [37] (Davies AJA, Meagher JA agreeing). Where the operation of s 21 extends to persons (including corporations) who can “know” only through agents, the knowledge of relevant employees and agents may be taken into account: Permanent Trustee v FAI at [86] (Gummow and Hayne JJ).
Three examples of matters which a reasonable insured could be expected to know to be relevant to the insurer’s decision whether to accept the risk and, if so, on what terms, may assist. A substantial expansion of the insured’s business could be relevant to the risk of damage to the premises or the risk of fire: GIO v Wallace at [26]. The fact that the premises are being used as a brothel may qualify, as “such use of premises could put the safety of the premises in danger” including by reason of arson, standover tactics, fights and dissatisfied customers: Lindsay v CIC Insurance Ltd (1989) 16 NSWLR 673 at 684 (Rogers CJ in Comm D). The fact that the insured in sharing industrial premises with another and that other has brought “a substantial body – probably upwards of a thousand litres at least – of highly flammable chemical” onto the insured premises may also qualify: Prime Forme Cutting Pty Ltd v Baltica General Insurance Company Ltd (1991) 6 ANZ Insurance Cases 61-028 at 76,879 (Tadgell J).
Given my earlier findings, the insureds’ duty of disclosure continued up to and including 31 March 2020. Given the complete replacement of the terms of the policy, the duty of disclosure up to that date applied in respect of matters that were material to the whole contract, not just to those matters that were material to the variation: Kelly & Ball, Principles of Insurance Law at [2.0080].
It is relevant at this point to consider what Sphere knew as at 31 March 2020 in respect of – not only its plans to make hand sanitiser – but its plans to bring bulk ethanol on site for that purpose. And this brings me back to Mr Cai’s email of 23 March 2020 and the gap in documentation until a purchase order was placed on 3 April 2020.
As to Mr Cai’s email of 23 March 2020 (see [134]), I draw no inferences in favour of the insureds in respect of the absence of documents evidencing Mr Cai’s negotiation with the Chinese supplier referred to in his email. What I do know is that Mr Cai said that he became involved in Sphere’s manufacture of hand sanitiser in his capacity as Group Planning and Resources Manager to assist with, among other things, procuring ethanol. His involvement had begun a fortnight earlier, on 10 March 2020: see [85].
I have already described Mr Mufaddal’s travails in sourcing bulk ethanol from Wilmar BioEthanol. Mr Mufaddal’s entreaties had produced a firm “no” from the supplier on 18 and 19 March 2020. (Mr Cai said he was not copied on Mr Mufaddal’s emails with Wilmar BioEthanol on 18 and 19 March 2020 and so was unaware of the status of their dealings.) On being told that the supplier could not assist, Mr Mufaddal contacted Redox again on 19 March 2020. Redox advised at 3.26 pm on Friday, 20 March 2020 that it could not assist either: see [117]. (There is no evidence that Mr Cai was unaware of this communication). In Hong Kong, where the merchant of the ethanol that was ultimately purchased was based, it was then 12.26 pm.
By 6pm on Monday, 23 March 2020, Mr Cai reported to his colleagues, “I managed to negotiate with some Chinese supplier”. Where Mr Cai noted in his email that Sphere “urgently need alcohol” and it would be “a disaster” if he could not procure it, it is likely that Mr Cai decided to look at importing ethanol from overseas when it became apparent that Mr Mufaddal had been unsuccessful, which was on 20 March 2020. (Indeed, where Mr Mufaddal was told the bad news by Redox four hours before Mr Keuneman bound cover on the contract of insurance, Mr Cai might have begun these negotiations before the contract of insurance was formed, though I do not think it matters: see [125].) But in terms of the sheer availability of business hours to undertake negotiations, it is more likely that he “managed to negotiate with some Chinese supplier” on Monday, 23 March 2020.
I draw no inferences in favour of the insureds in respect of the absence of documents evidencing Mr Cai’s negotiation with the Chinese supplier from 23 March 2020 until a purchase order was placed with the supplier on 3 April 2020. There must have been multiple communications over this period. Mr Cai was advised on 24 March 2020 by Mr Peiris that there was no problem using imported alcohol from a QA point of view. It is likely that Mr Cai pursued negotiations with the Chinese supplier in earnest from 24 March 2020 in parallel with Sphere’s efforts to secure ethanol from local suppliers Wilmar BioEthanol and Redox, as well as Fonterra in Auckland. The price of local ethanol was rapidly increasing: see [181]. Sphere was trying to source Ethanol 94 instead but was still having no luck, as advised by suppliers on 24 and 26 March 2020.
Where Mr Mufuddal had been trying to source between 40,000 L and 50,000 L of ethanol, presumably Mr Cai was negotiating the supply of at least that amount. This was about ten times the amount of ethanol that Sphere usually held on site. Obviously enough, an importation of bulk ethanol was not going to be a “split deliver”. But Sphere’s previous concerns as to “how they were going to manage the ethanol on site” had been put to one side.
As at 31 March 2020, a reasonable person in the circumstances of Sphere could be expected to know that the company had decided to make a new product, the main ingredient of which was a flammable liquid, ethanol. The company had completed the research and development phase. The manufacturing equipment had been tested with a trial run. Modifications had been made to its liquid manufacturing section to “explosion proof level” given that the ethanol concentration for the product was 75%. All other ingredients had been sourced, including bottles, pumps and fragrance. The first customer was printing labels.
Given current shortages in ethanol supplies locally, Sphere had decided to import a bulk shipment of ethanol from overseas. The company was in advanced negotiations with the supplier. This ingredient was usually stored in Sphere’s dangerous goods area. The dangerous goods area had insufficient capacity to store the amount of ethanol that was expected to be sourced from this supplier, which was about ten times the amount usually held on site. Sphere did not know how they were going to manage the ethanol on site.
This case is distinguishable from Prime Forme Cutting v Baltica General Insurance in that Sphere did use ethanol and was not bringing this flammable substance onto the site for the first time. But the insured was planning to bring a bulk quantity of the substance onto the site in circumstances where it would significantly exceed the capacity of the dangerous goods storage area. As to whether a reasonable person could be expected to know that this was a matter relevant to the decision of the insurer whether to accept the risk and, if so, on what terms, I consider that a reasonable insured would have known this.
From the RIRs provided by Allianz in the past, which the company had completed from time to time, the insurer had made a series of recommendations in respect of fire protection systems and thus was apparently interested in that subject. Where the insurer was being asked to provide cover of $26.8 million, the insurer’s interest in such a subject was unremarkable.
Being in possession of the RIRs, a reasonable insured would have known that the insurer had inspected the site in December 2015 and was aware that the insured stored flammable liquids in the dangerous goods storage area. A reasonable person in the circumstances could be expected to know that the fact that the insured was arranging to bring bulk ethanol onto the site which significantly exceeded the capacity of that area would be relevant to the decision of the insurer whether to accept the risk and, if so, on what terms. Sphere did not comply with its duty of disclosure.
The insurer contended that it would not have entered into the policy at all, or for the same premium, or on the same terms and conditions, if the decision to manufacture hand sanitiser had been disclosed. The insurer was entitled to reduce its liability to nil under s 28(3) of the Insurance Contracts Act. Further, where the acquisition and storage of the imported ethanol could reasonably be regarded as being capable of causing or contributing to the fire and its subsequent damage to the premises, the insurer was entitled to rely on s 54(2) of the Insurance Contracts Act. The insurer contended that it was entitled to reduce its risk to nil pursuant to Condition 2 of the policy: s 54(1), Insurance Contracts Act.
For their part, the insureds contended that Endorsement UNDISYB4 applied such that Allianz was entitled to request any reasonable extra premium to be paid by the insureds in respect of any non-disclosure. But where the insurer had not called any evidence as to what that additional premium was, the Court could not award this either. The insureds accepted that there was an alteration in risk but contended that the insurer remained liable to indemnify the insureds without deduction. (I have concluded that Endorsements UNDISYB4 and ALTERVS4 did not apply.)
The insurer submitted that it was entitled to reduce its liability to nil applying the approach in Zurich Australian Insurance Ltd v Cimic Group Ltd (2024) 115 NSWLR 297; [2024] NSWCA 229 at [189]-[191], [224]-[226] (White, Stern JJA and Griffiths AJA). That is, one starts with the matter not disclosed but is not confined to that fact on the counterfactual. Rather, one looks at the likely sequence of events had that disclosure been made. The underwriters did not simply say that, if they had known of the matter which ought to have been disclosed, then they would have immediately declined cover in any circumstances. Rather, the underwriters identified what would have happened if the disclosure had been made, that is, the counterfactual started with the disclosure but did not end with it.
But for the non-disclosure of the decision to make hand sanitiser during the policy period, the matter would have been referred by Mr Keuneman to Ms Lobo. Neither would have accepted the risk without an investigation by ARCA and advice or more information. Mr Iordanou set out further information which he would have recommended be obtained from the insured. Mr Iordanou would have recommended to the underwriters that his questions needed to be answered before cover could even be considered. It was unlikely that the answers to Mr Iordanou’s questions would have been provided by 20 March 2020, but even if it was, Mr Iordanou would then have inspected the premises and prepared an ARCA – Multi-Line Report. The counterfactual would involve days and weeks of enquiry, not hours. Ms Lobo and Mr Pocknee would not have accepted the risk without this information.
The insurer submitted that the time taken to complete these steps would have encompassed Sphere’s decision to order 60,000 L of ethanol from China. Either way, Mr Iordanou would have advised against accepting the risk following an inspection. Each of the underwriters said that, if there was an ARCA recommendation not to accept cover, then that would have been very influential.
The insureds submitted that Allianz’s evidence as to what it would have done had the decision to make hand sanitiser been disclosed relied on the incorrect proposition that the premises only had safe storage for 4000 L, when the capacity was said to well exceed this. (There was little evidence to support this proposition.) It also rested on the proposition that Sphere would be receiving a bulk delivery. This was said to be incorrect too, where Mr Mufaddal clearly had in mind a ‘split delivery’ when conversing with Wilmar BioEthanol about the delivery of 35,000 L. Sphere did not turn its mind to accepting delivery of the bulk shipment from China until much later.
The insureds submitted that the Court should not accept the proposition that notification of the decision to make hand sanitiser would have resulted in a change in Allianz’s classification of the risk under ANZSIC 1993 from Code 2543 to 2549, and a corresponding change in the fire rating, resulting in a decline. The ANZSIC Code that had always been applied to Sphere was a code within the class of ‘Other Chemical Product Manufacturing’. There was said to be no prospect of this business unit falling within the class of ‘Basic Chemical Manufacturing’. The performance of a single contract for the supply of hand sanitiser in May 2020 could not alter the applicable ANZSIC business classification, as the manufacture of hand sanitiser was antibacterial manufacturing, being an activity identified with ANZSIC Code 2543. Where the underwriters said that they relied on ARCA to designate the ANZSIC code, that was Mr Iordanou. He accepted that hand sanitiser was an antibacterial product, and antibacterial manufacture was accommodated within ANZSIC Code 2543. He agreed that he would need to know a lot more about the business activities of the insured to re-classify. Given that Sphere had not even commenced the manufacture of hand sanitiser, there was no realism in a change in the code.
The insureds submitted that the other way for Allianz to decline the policy would be if the fire rating was designated at 9, by analysing the risk against the AQS. This was also a job for Mr Iordanou. The Court could not reasonably conclude that, had the decision to make hand sanitiser been disclosed, ARCA would have issued a Property Risk Acceptance and Rating Guide with a loading sufficient to trigger any special referral or recommended decline. There was no proper basis to conclude that, on the balance of probabilities, this risk would have carried a fire risk rating of 9. Allianz had adduced no evidence from Mr Keuneman or Ms Lobo of what their response would have been if the risk did not reach the necessary higher rating to refer, and it was left to them to decide on the basis of a more modest loading. This lack of evidence was said to be the product of the forensic choices that Allianz has made in this case to adopt an extreme position that was not rationally supported by the evidence.
(1) This section applies if a relevant failure occurs in relation to a contract of general insurance, but does not apply if the insurer would have entered into the contract, for the same premium and on the same terms and conditions, even if the failure had not occurred.
…
(3) If the insurer is not entitled to avoid the contract or, being entitled to avoid the contract … has not done so, the liability of the insurer in respect of a claim is reduced to the amount that would place the insurer in a position in which the insurer would have been if the relevant failure had not occurred.
(a) The onus of proof is on the insurer to prove what would have happened if the insured had made disclosure when it should have and what the insurer would have then done. (b) It is not necessary for the insurer “to prove each step that would have been taken within its organisation” in the counterfactual, nor does s 28(3) “specify any particular mode of proof”: at [190] quoting Prepaid Services v Atradius at [71]. The insurer’s witnesses may explain what they would have done if particular information was disclosed or, more broadly, what was important to their decision making. (c) It may be cumbersome and confusing for the insurer to address all permutations of what the Court may find should have been disclosed. If the insurer’s evidence is based on assumptions which do not perfectly align with the Court’s findings, the evidence may still have probative value; nor should the Court decline to infer that the insurer would have responded in a similar way. The position may be different if there are material differences between the assumptions made by the insurer’s witnesses and what the Court has found. (d) The Court should be mindful that such evidence “is given through the “prism of hindsight” [and] needs to be assessed not simply on the basis of the credit of the witness, but also by reference to the objective probabilities”: at [191] citing Stealth Enterprises Pty Ltd t/as The Gentleman’s Club v Calliden Insurance Ltd [2017] NSWCA 71 at [87] (Sackville AJA).
The task when considering an insurer’s claim to reduce their liability under s 54 of the Insurance Contracts Act is essentially the same. The Court examines the counterfactual situation to determine what the insurer would have done had the act or omission of the insured occurring after the contract was entered into not occurred: Ferrcom Pty Ltd v Commercial Union Assurance Co of Australia Ltd (1993) 176 CLR 332; [1993] HCA 5 at 340 (Brennan, Deane, Dawson, Gaudron and McHugh JJ); Moltoni Corporation Pty Ltd v QBE Insurance Ltd (2001) 205 CLR 149; [2001] HCA 73 at [24] (Gleeson CJ, Gaudron, McHugh, Kirby and Hayne JJ).
The challenge presented by an insurer’s evidence dealing with a number of permutations and combinations is pertinent here. The insurer’s witnesses made two ‘rounds’ of affidavits. The first ‘round’ was made when the parties were proceeding on the basis that the contract of insurance was formed on 20 March 2020. When the matter was first listed for hearing September 2025, the hearing was vacated when it became apparent that, given the WA broker’s instructions to cancel that policy and the issue of a new policy by Mr Pan, the contract of insurance may have been formed later.
The first ‘round’ of affidavits also proceeded on the basis that the insureds were manufacturing hand sanitiser, while the second ‘round’ proceeded on the basis that the insureds had decided to make hand sanitiser but had yet to commence production. Other permutations included the different volumes of ethanol which the insureds had ordered or which was on site at particular points in time.
The witnesses also proceeded on the assumption that the ARCA – Multi-Line Reports indicated that up to 4,000 L of flammable liquids could be stored on the site. As earlier noted, that is not precisely what the reports said. More accurately, the reports indicated that that was how much Sphere had been storing historically, not the maximum amount that it could store. On the limited available evidence, I have concluded that the dangerous goods area could have stored 10,000 L of ethanol in addition to the regular supply of ethanol for the company’s manufacturing processes.
As I have concluded that Sphere had a duty of disclosure up to and including 31 March 2020, the underwriter who would have considered the matter was Mr Pan. He would have considered the matter on the basis that Sphere was not manufacturing hand sanitiser but had decided to do so and, in order to do so, had decided to order a bulk shipment of ethanol from Shanghai, the size of which exceeded its dangerous goods storage area.
Further, Mr Pan would have considered the matter on the basis that the contract of insurance had been formed on 20 March 2020 but the contract of insurance had been wholly varied on 31 March 2020 such that the insured’s duty of disclosure continued to that date. That is, in the somewhat unusual circumstances of this case, when one considers what the insurer would have done if the insured had made disclosure when it should have, Mr Pan would not have been considering whether to underwrite the policy in the first place but what to do about the existing policy.
As to cancellation of the existing policy made on 20 March 2020, Condition 5(b) of the Austbrokers policy wording was the same as the Steadfast wording and provided:
“The Insurer(s) may also cancel this Policy by giving the Insured written notice to that effect where:
…
(ii) the person who was the Insured at the time when this Policy was entered into failed to comply with the duty of disclosure;
…”
In that event, cancellation took effect on the earlier of 13 business days after notice was given or the insured obtaining a new policy: Condition 5(c).
Where Condition 5(b)(ii) adopts the same language as s 21(1) of the Insurance Contracts Act, I take it that the parties intended that the time when the policy was entered into included an agreement to vary the contract: s 11(9), Insurance Contracts Act. For reasons earlier given, I have concluded that the insured failed to comply with the duty of disclosure at the relevant time, being 31 March 2020. The insurer was entitled to cancel the existing policy on this basis.
While Mr Pan had only been an underwriter at Allianz for four months at the time, he had already been an underwriter elsewhere for six years. Mr Pan was aware at the time that ethanol was used in the production of hand sanitiser. He understood that Allianz had written the risk on the basis that, according to the ARCA – Multi-Line Reports, up to 4,000 L of ethanol (or other flammable liquids) could be safely stored on site. The safe storage of 4,000 L of flammable liquids in IBCs within metal cages in a bunded area was part of the risk identified by the ARCA Risk Engineers. He understood that the risk had been written on that basis. In cross-examination, Mr Pan accepted that the ARCA – Multi-Line Reports did not indicate that 4,000 L of ethanol was the maximum safe storage limit. But Mr Pan was correct in his understanding that the risk had been written on the basis that 4,000 L was then stored on site.
Mr Pan said that if he had been informed that Sphere had made a decision to manufacture hand sanitiser from the premises, then he would have asked for further information regarding the amount of hand sanitiser Sphere intended to manufacture and the manner in which it intended to store the ethanol required for the manufacturing process. He would also have informed the NSW Branch Underwriting Manager, Andrew Weston, and requested urgent input from ATS and ARCA. The decision to proceed with underwriting the increased risk posed by the manufacture of hand sanitiser would have been outside the level of Mr Pan’s underwriting authority. He would have needed approval from Mr Weston and possibly ATS, subject to Sphere’s responses to his enquiries and an ARCA assessment of the risk.
If Mr Pan had been informed that Sphere had ordered, or was about to order, some 60,000 L of ethanol in bulk from overseas, to be stored at the premises, he said that he would have taken urgent action. Mr Pan would have considered the storage of such a large quantity of flammable material to be a significant increase in the risk. Mr Pan would have asked questions (through the broker) in relation to the manufacture of hand sanitiser, including how much ethanol or hand sanitiser (finished product) was to be stored at the premises, where at the premises they were to be stored and how. Mr Pan would have informed the NSW Branch Underwriting Manager, Mr Weston, as the decision regarding whether to underwrite the risk would have been above Mr Pan’s underwriting authority. It is likely that input from ATS and ARCA would have been required if the underwriting was to proceed.
As to alteration of risk, Mr Pan understood that the manufacture of hand sanitiser and the storage of ethanol and hand sanitiser was a material change in the risk and would fall within a different risk category for Allianz’ underwriting, being chemical manufacturing. Mr Pan believed that he would also have requested that ARCA inspect the premises and review the alteration of risk. Based on Mr Pan’s understanding of the manner in which the premises were being managed before the fire, and if he had been informed about the manufacture of hand sanitiser, he would have recommended that the policy be cancelled.
As to what input ATS would have given if asked by Mr Pan, where Sphere had disclosed an intention to move into the production of hand sanitiser but no manufacture had taken place, Mr Pocknee said, “I’ve assumed that this was going to happen within the policy period, therefore, [it] would be a material fact that we would have had to consider at that stage.” He disagreed that this did not alter the insurer’s risk. Mr Pocknee said he would have reviewed any ARCA assessment of the risk, as he would expect such a risk to be assessed by ARCA. He would have considered the adequacy of the risk management controls at the premises including the adequacy of the safe storage facilities (such as IBCs and bunding) for the storage of ethanol, the adequacy of the fire protection to store highly flammable raw materials or end product, and that the storage of both flammable raw materials and finished products was physically separated from core manufacturing operations.
If Mr Pocknee had been advised that Sphere did not have a plan in place about where and how to store the ethanol or the finished product, he would not have supported the acceptance of the risk as the production of hand sanitiser would probably be categorised as chemical production / storage by ARCA as it involves large quantities of ethanol, a highly flammable raw material, together with the absence of safe storage facilities (such as IBCs and bunding) and fire protection at the premises.
If Mr Pocknee had been advised that Sphere was looking to acquire around 60,000 L of ethanol from China, which was likely to arrive at the premises in one delivery, this would have made it more likely that he would not have supported the acceptance of the risk. He was not aware of any risk of this kind being accepted by Allianz for an ISR policy, namely manufacturing involving large quantities of alcohol without any plan for the safe storage of the raw material or finished product.
Mr Pocknee said Allianz’s appetite for underwriting high risk chemical manufacturing depended on the fire hazard rating and whether Allianz considered that the risk could be adequately managed. Allianz’s underwriting appetite fell away the higher the fire risk rating. From his experience as manager of ATS, this risk was a high fire risk rating and Allianz would not have underwritten the risk. The insurer would have cancelled the policy. If underwriters had referred the matter to him, then Mr Pocknee said that he would not have supported the continuation of cover. He would have supported a recommendation by the underwriter that the policy be cancelled and would have given Sphere 14 days to find alternative cover.
As to what ATS would have done if asked about an alteration in risk after policy inception, Mr Pocknee said that if Sphere was manufacturing hand sanitiser from the premises and some 60,000 L of ethanol had been delivered to the premises from overseas and stored at the premises in plastic barrels until use, this altered the risk category from ANZSIC Code 25430 “Pharmaceutical and Medicinal Product Manufacturing” to “Chemical Manufacturing”. He disagreed that this assumption was not enough information to conclude that there was a change in risk category. Mr Pocknee said that if Allianz had been notified of this, ARCA would have been asked to inspect the premises and advise on the increased hazard. Due to the bulk storage of flammables, he would expect that this risk would have been assessed by ARCA at fire hazard 9, being the highest level. Such a risk would have to be referred to ATS.
As to whether Allianz would have agreed to take on the additional risk under the alteration of risk provisions, Mr Pocknee’s experience in property underwriting over the years was that, if there was a change in the nature of the risk, the risk would be re-underwritten “and we had certainly looked at cancellation of other policies in the past where the fundamental risk had changed.” If Allianz had been informed of a decision to manufacture, “we would have had to have a discussion about re-underwriting that risk and potentially issued a notice of cancellation.” Mr Pocknee said that an underwriter, if informed about a substantive change to a risk which changed the risk category, would have had “a sensible conversation with a broker on behalf of the end client and they would come to an agreement. If the risk was to change fundamentally, these things tend to work themselves out without having to get to a pure legal definition or challenge” in respect of the rights of cancellation.
Mr Pocknee rejected the proposition that the insurer would not have cancelled the policy absent a change to the physical circumstances of the premises, “The introduction of flammable liquids into … inappropriate storage facilities would have … put it into a risk hazard 9 which nobody had the authority in Australia to underwrite on their own. So that would have required escalation and we never would have done it given the information that subsequently came to light regarding storage.”
Mr Pan and Mr Pocknee’s views accorded with those of Ms Lobo, who would have considered the matter in the counterfactual if the date of disclosure was 20 March 2020. If she had been told at the time that Sphere intended to move into the production of hand sanitiser, Ms Lobo would have reviewed the ANZSIC code and believed that she would have formed the view that the production of hand sanitiser was likely to be characterised as chemical production / storage due to the use of ethanol, which involves a high-risk rating of level 9. Ms Lobo did not think that there was any relevance to whether Sphere had contract orders in place to produce hand sanitiser. Ms Lobo regarded going from non-flammable pharmaceutical production to chemical product production as a major change, “it change[s] the risk totally. … hand sanitiser includes … large quantities of ethanol which is different from non-flammable pharmaceutical production”.
Ms Lobo would have asked Mr Keuneman to seek more information from Sphere through its broker including details of what the proposed production of hand sanitiser involved, the likely quantity of ethanol involved, any safety measures including a fire sprinkler system at the premise, and proposed measures for the safe storage of ethanol and finished product including any necessary modifications to the premises. If the answers received from Sphere as to its intentions indicated that the production of hand sanitiser could be considered by Allianz as incidental, by which Ms Lobo meant less than 10% of Sphere’s overall production, then it was possible that the insurer could have considered the risk. In that event, Ms Lobo would have referred the risk to ATS for review depending on the outcome of ATS’ review, a decision would have been made either to decline the risk or to request an ARCA survey to confirm the information provided by the insured before a decision was made.
If Ms Lobo had been advised that Sphere was looking to acquire around 60,000 L of ethanol from China which was likely to arrive at the premises in one delivery , did not have in place a plan about where or how to store the ethanol or the finished product, then Ms Lobo would have declined cover without the need to refer the risk to ATS. In this situation, the risk was clearly one which she would have declined.
As to what input ARCA would have given if asked by Mr Pan, Mr Iordanou said that if he had been asked by underwriters to inspect the Moorebank site at a time before the production of hand sanitiser and the storage of large amounts of ethanol had begun, he would not have attended as there was nothing that such an inspection would reveal. He would have provided an analysis of risk without an inspection. To do this, he would need to know what the relevant intention of the business was.
Mr Iordanou knew at the time that hand sanitiser was made up of flammable liquid, being some type of alcohol. As such, he would have needed to know the details of the processes to be undertaken to take the raw ethanol to a finished product, including whether heat was to be applied. He would need to know the detail around any proposed emergency facilities, including to account for a possible burst pipeline or hose. He would need to know the proposed size of the anticipated production including the volume of raw materials to be stored and used. He would need to know where the raw materials were to be stored and how they were to be protected from fire, spill and collision risks, including whether they were to be contained in a bunded area and / or protected by fire protection systems. Mr Iordanou would have needed to know working progress storage and capacity, finished product storage and capacity, whether there were any applicable manufacturing or storage standards with which to comply, and whether any other processes would add to the fire load of the premises.
If Sphere was unable to answer his questions, Mr Iordanou would have recommended to underwriters that they require the proposed insured to answer the questions before cover could be considered. Depending on how his questions were answered, Mr Iordanou said that if he was providing advice about risk prior to policy inception, he would have considered the need to re-classify the risk as chemical manufacturing and to apply a premium loading. Mr Iordanou would not then have been able to produce an ARCA – Multi-Line Report, as he would not have had cause to inspect the premises until the changes had been implemented to enable the manufacture of hand sanitiser on site.
Mr Iordanou said that if the answers from Sphere had revealed that it had been attempting to source some 60,000 L of ethanol from China, to be delivered at one time, did not have a place for the safe storage of that ethanol, could not provide details for emergency stock facilities to account for a burst pipeline or hose and did not have in place a plan for the safe storage of the finished product, he would have advised the underwriters against accepting the risk.
Mr Iordanou said that if he had been asked by underwriters to inspect the premises and assess any alteration in risk due to the production of hand sanitiser and the storage of large quantities of ethanol on site, he would have inspected the premises to review the heightened risk in the production of the hand sanitiser, storage of the finished product and the storage of ethanol. He would have reviewed the processes used by Sphere in the production process, the quantities of ethanol being stored, how the ethanol was being stored and whether the means of storage was safe. He would have reviewed how much and where the finished product was being stored. He would have considered whether most of the ethanol could be stored off site in a secure storage facility, as the premises had safe storage facilities for only 4,000 L of ethanol.
Mr Iordanou said he would have considered whether Sphere needed storage licences or a dangerous goods licence for the storage of large quantities of ethanol. But his recommendations would have primarily concerned the storage facilities. Mr Iordanou would have queried why Sphere needed to have such large quantities of ethanol on site at one time. He would at least have recommended that the ethanol be moved offsite to a secured dangerous goods logistics storage facility until required for production.
Mr Iordanou said that the assessed risk in the Property Risk Acceptance and Rating Guide prepared after inspecting the premises would have increased to a higher risk occupancy, likely to be a Fire Hazard Index of 9. This would be due to a reclassification of the risk as chemical manufacturing. Alternatively, he would have applied a loading via the insurer’s relativity system. In that case, the Fire Hazard Index would remain at 6 but the risk rating AQS would be loaded to generate a premium for Fire Hazard Index 9. In these circumstances, the risk would have been referred to ATS. His assessment of the risk posed by the bulk storage of ethanol alone would likely have increased the level of the fire risk to an automatic decline / cancellation category.
Mr Iordanou agreed that he would need to know a lot about the business activities of the insured before he decided to change the ANZSIC Code. Mr Iordanou agreed that the appropriate industry category was the one that best fitted the predominant activities of the business unit. Before changing the ANZSIC Code, he needed to know whether the manufacture of hand sanitiser was of such a scale that the predominant business activity of Sphere had changed because of that manufacture. He needed sufficient information to consider the relative significance of each of the activities of Sphere. Although antibacterial manufacture was listed as a primary activity within ANZSIC Code 2543, Medicinal and Pharmaceutical Product Manufacturing, Mr Iordanou did not agree that there was no need to change the ANZSIC Code. Somewhat confusingly, Mr Iordanou also agreed in cross-examination that ANZSIC 25430 was the correct code and that he did not have enough information at the time to change the ANZSIC Code.
Although the assumptions made by the insurer’s witnesses have not aligned perfectly with my findings, it is tolerably clear how they would have acted, that is, their evidence continues to have probative value.
Fairly obviously, if Sphere had disclosed its plans to acquire bulk ethanol to make hand sanitiser, then Allianz would not have entered into the contract of insurance for the same premium and on the same terms. Whether the insurer would have accepted the risk but on payment of an additional premium depends on the evidence of the insurer’s witnesses.
Mr Pan would have sought urgent advice from ATS and ARCA. ATS would have sounded a note of extreme caution and supported a recommendation by Mr Pan to cancel the policy.
ARCA would have provided a list of questions to be answered by Sphere before proceeding any further. Mr Pan would not have underwritten the risk or agreed to an alteration in risk without ARCA’s input. Where Sphere’s plans to import bulk ethanol and to store that material on site were progressing day-by-day, it is likely that the full extent of Sphere’s plans would have become known by the time that Sphere answered Mr Iordanou’s questions and before ARCA provided any advice to Mr Pan.
As to whether the proper classification of Sphere’s activities under ANZSIC was Code 2543 or “chemical manufacturing”, I do note that Mr Iordanou appeared to become confused on occasion, particularly when asked about ANZSIC Code 25430. I approached some of his answers with caution for this reason. Ms Lobo was a thoughtful and impressive witness. Mr Pocknee was also clear and forthright. Where three senior underwriters considered that Sphere’s activities would have re-classified as chemical manufacturing, I defer to their collective expertise.
But whether the proper classification of Sphere’s activities under ANZSIC was Code 2543 or chemical manufacturing is not really what caught the underwriter’s eye. It was the fact that, whatever code Sphere’s activities fell under, the insured was planning to have a quantity of a flammable liquid on the insured premises which significantly exceeded the existing arrangements on those premises for the safe storage of that liquid. That was the matter which made the risk unacceptable, and it is easy to see why. A flammable liquid, by its nature, posed a risk of ignition. If that risk was realised, then it was important to contain the damaging effects of that ignition so that the insured property was not imperilled at large.
I accept the consistent evidence of the insurer’s witnesses that this risk was not one which the insurer would have accepted in the counterfactual, whether presented in discharge of Sphere’s duty of disclosure on 31 March 2020 or under the ‘alteration of risk’ provision. Where the bulk ethanol significantly exceeded the insured’s ability to safely store the flammable material, I am satisfied on the balance of probabilities that the insurer would not have agreed to accept that risk. The insurer is not liable to indemnify the insureds in respect of their claim under the policy.
For these reasons, I make the following orders:
Dismiss the Summons with costs.
Parties to notify any errors or omissions within 7 days.
Any party seeking to vary the costs order is to provide any affidavits and submissions (limited to 3 pages) in support of the costs order they seek within 14 days, with any affidavits and submissions in reply (limited to 3 pages) to be provided within a further 14 days and the matter to be decided on the papers.
**********
Coversheet: hearing dates amended; cross-references amended
[2008] HCA 30
[2010] HCA 9
(2014) 224 FCR 1
(1989) 166 CLR 606
(2002) 119 FCR 307
(2001) 114 FCR 39
(1999) 47 NSWLR 735
(2020) 270 CLR 523
(1979) 143 CLR 24
(1987) 163 CLR 303
(1993) 176 CLR 332
(2023) 280 CLR 442
(2001) 51 NSWLR 572
(1959) 101 CLR 298
(1989) 16 NSWLR 673
(2000) 203 CLR 589
(2001) 205 CLR 149
(2003) 213 CLR 514
(2018) 97 NSWLR 459
(2010) 240 CLR 444
(2024) 115 NSWLR 297
(2009) 240 CLR 391
(2003) 214 CLR 514
(2000) 203 CLR 579